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Abstract
The P2X7 receptor (P2X7R) is an ionotropic receptor that responds to high concentrations of extracellular
adenosine triphosphate (ATP) leading to NF-κB-mediated inflammatory responses. P2X7 receptors are
important regulators of microglial cells, the innate immune effector cells of the central nervous system
(CNS). P2X7R stimulation and microglial morphological and molecular changes have been implicated in
loss of neurons accompanying elevation of intraocular pressure (IOP) and associated ATP release.
However, the mechanisms linking these processes remain unclear. Recent developments implicating
astrocyte inflammation as the intermediaries between microglia inflammation and neural loss further
complicate the relationship. We sought to interrogate the consequences of P2X7R stimulation to
microglia morphology, the molecular alterations to microglia and astrocytes, in the retina, and the P2X7R
role in loss of neurons from transient elevation of IOP. We administered P2X7R agonist BzATP to mice
retinae to examine microglia morphological differences and inflammatory gene expression differences.
This work was supported with in vitro exposure of cultured microglia to P2X7R stimulation. Finally, we
used a model of elevated IOP to determine the effects on microglia and astrocytes. We found that retinal
exposure to BzATP led to process retraction and elevation of Iba1 in microglia, as well as elevation of
both pro-inflammatory (Tnfa, Nos2) and anti-inflammatory (Arg1, Chil3) markers. Transient elevation of
IOP induced similar microglial process retraction and retinal gene expression, and these morphological
and molecular differences were dampened in retinae derived from P2X7-/- mice. BzATP-injected retinae
upregulated genes associated with induction of astrocyte neurotoxic inflammation. Finally, loss of neural
populations in retinae subjected to elevated IOP was reduced in retinae from P2X7-/- mice. Furthermore,
as P2X7R affects multiple metabolic processes, we sought to review literature to examine the intersection
between microglial P2X7R stimulation and microglia phagocytosis or autophagy. We outlined P2X7Rmediated reduction of phagocytosis, transient induction of autophagy, and disruption of microglia
lysosomes with longer exposure, and demonstrated a role for lysosomal leakage in cytokine release.
These studies highlight the diverse consequences of microglial P2X7R stimulation, and indicate that
stimulation plays a key role in retinal degeneration accompanying elevated IOP.
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ABSTRACT

P2X7 RECEPTOR STIMULATION AND ELEVATED INTRAOCULAR PRESSURE RAPIDLY
ALTER MICROGLIA MORPHOLOGY, STATE MARKERS, AND CYTOKINE RELEASE
Keith Campagno
Claire Mitchell

The P2X7 receptor (P2X7R) is an ionotropic receptor that responds to high concentrations
of extracellular adenosine triphosphate (ATP) leading to NF-κB-mediated inflammatory responses.
P2X7 receptors are important regulators of microglial cells, the innate immune effector cells of the
central nervous system (CNS). P2X7R stimulation and microglial morphological and molecular
changes have been implicated in loss of neurons accompanying elevation of intraocular pressure
(IOP) and associated ATP release. However, the mechanisms linking these processes remain
unclear. Recent developments implicating astrocyte inflammation as the intermediaries between
microglia inflammation and neural loss further complicate the relationship. We sought to interrogate
the consequences of P2X7R stimulation to microglia morphology, the molecular alterations to
microglia and astrocytes, in the retina, and the P2X7R role in loss of neurons from transient
elevation of IOP. We administered P2X7R agonist BzATP to mice retinae to examine microglia
morphological differences and inflammatory gene expression differences. This work was supported
with in vitro exposure of cultured microglia to P2X7R stimulation. Finally, we used a model of
elevated IOP to determine the effects on microglia and astrocytes. We found that retinal exposure
to BzATP led to process retraction and elevation of Iba1 in microglia, as well as elevation of both
pro-inflammatory (Tnfa, Nos2) and anti-inflammatory (Arg1, Chil3) markers. Transient elevation of
IOP induced similar microglial process retraction and retinal gene expression, and these
morphological and molecular differences were dampened in retinae derived from P2X7-/- mice.
BzATP-injected retinae upregulated genes associated with induction of astrocyte neurotoxic
inflammation. Finally, loss of neural populations in retinae subjected to elevated IOP was reduced
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in retinae from P2X7-/- mice. Furthermore, as P2X7R affects multiple metabolic processes, we
sought to review literature to examine the intersection between microglial P2X7R stimulation and
microglia phagocytosis or autophagy. We outlined P2X7R-mediated reduction of phagocytosis,
transient induction of autophagy, and disruption of microglia lysosomes with longer exposure, and
demonstrated a role for lysosomal leakage in cytokine release. These studies highlight the diverse
consequences of microglial P2X7R stimulation, and indicate that stimulation plays a key role in
retinal degeneration accompanying elevated IOP.
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CHAPTER 1: INTRODUCTION
1.1 What is ‘neuroinflammation’?
Inflammation is the process by which immune cells respond to harmful stimuli, such as
damaged tissue or pathogens. Within the Central Nervous System (CNS), neuroinflammation is
mediated by glial populations that communicate with direct interaction, chemokines, cytokines, and
reactive oxygen species (ROS) as a protective mechanism to eliminate pathogens, repair tissue
and restore homeostasis437. The context and duration of the neuroinflammatory processes
determine if the outcomes are beneficial or detrimental, but are currently appreciated as
encompassing

a

large

role

in

neurodegenerative

conditions92,149,437.

Amelioration

of

neurodegenerative conditions requires close study of the cell origin, effectors, and receptors that
contribute to neural pathogenic neuroinflammation.
1.2 The P2X7 receptor: diverse functions and inflammatory consequences
In 1972, adenosine triphosphate was proposed to be more than a mere intracellular energy
molecule, but an important regulator of neurotransmission in nerve stimulation of gut and bladder
smooth muscles49 Furthermore, ATP was found to be released with neural stimulation in the
peripheral and Central Nervous Systems (CNS)49. Since then, identification of receptors that are
stimulated with purines has led to a deeper understanding of inflammation arising from danger
signals and tissue injury. These receptors are classified into P1 receptors, which respond to
adenosine, and P2 receptors, which are stimulated with adenosine diphosphate (ADP) or ATP. P2
receptors themselves are subdivided into ionotropic P2X receptors, which bind ATP, and P2Y
metabotropic receptors, which respond to ATP and ADP234.
The P2X7 receptor (P2X7R) is a member of the P2X ionotropic purinergic receptor family
that is permeable to Na+ and Ca2+ influx, and K+ efflux. Seven mammalian receptors of the P2X
family have been discovered to date, with P2X7 being the newest discovery395. P2X7R is a homotrimeric receptor413 that alters conformation to open at high (0.1 to 5 mM) concentrations of
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ATP107,395. Each P2X7 subunit consists of an extracellular loop that participates in agonist and
antagonist binding, and cytoplasmic N- and C-terminal domains148,184,273. Interestingly, P2X7R does
not desensitize after binding due to a C-cys anchor binding to the inner plasma membrane via
palmitoyl groups273.
Experimental evidence has indicated that P2X7R has three major physiological states,
which are dependent upon concentration of ATP and length of stimulation90,110,184 (Figure 1.1). In
the closed state, unstimulated by ATP, P2X7R can act as a scavenger receptor that can
phagocytose bacteria and apoptotic cell material139-141. This property of P2X7R is of particular
interest in the CNS, as P2X7R-mediated scavenger receptor activity is inhibited when exposed to
the serum fraction that contains zinc- or copper-glycoproteins137. Upon exposure to sufficient
concentrations of ATP, phagocytic capacity is inhibited139, and the trimeric subunits rotate to open
and allow ion passage. Elimination of phagocytic capacity after exposure to ATP is likely due to
dissociation from the P2X7 receptor from cytoskeletal component non-muscle myosin heavy chain
IIA with roughly the same kinetic timing as channel opening138. Channel opening and ion passage
is associated with the most studied aspects of P2X7R signaling, with numerous downstream
effectors driven by direct interactions210, by K+ efflux294, or Ca2+ influx69, activating metabolic
pathways, autophagy, death pathways, and especially inflammation314.
A putative third function of P2X7R stimulation is a macropore opening. Exposure to ATP in
vitro at higher concentrations or for prolonged time (on the order of seconds184) allows for
permeation of large molecules of up to 900 Da. The mechanisms leading to pore formation remain
unclear. Truncation of the unstructured C-terminus eliminated large molecule permeation while
maintaining channel activity2,395.

The subsequent cell death demonstrated with in vitro

experimentation contributed to the labeling of P2X7R as a “death receptor”395,420. The labeling is
questionable; it has since been demonstrated that P2X7R stimulation may promote
proliferation28,284, even in environments with elevated ATP levels, such as the tumor
microenvironment89,91 Additionally, widespread distribution of P2X7R indicates that cell death
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should be much more common89,91. Furthermore, macropore opening has never been observed in
vivo, suggesting that macropore opening may be an artifact of in vitro manipulation91.

Figure 1.1. General functions of the P2X7 receptor. A Without stimulation by ATP, P2X7R
functions as a scavenger receptor for cell debris or apoptotic cells. B Transient or low
concentrations of ATP allow for channel opening and efflux of K+, and influx of Na+ and Ca+ to
stimulate downstream processes. C Prolonged or high concentrations of ATP lead to putative
opening of a macropore. This macropore allows permeation by large biomolecules such as YOPRO or Ethidium Bromide, while efflux of cytokines such as IL-1β have been demonstrated.
The most widely recognized inflammatory pathway downstream of P2X7R signaling is the
NOD-, LRR, and pyrin domain-containing protein 3 (NLRP3) Inflammasome. The NLRP3
inflammasome is a multimeric compound that acts as an intracellular sensor responding to a
number of danger signals and producing cytokine Interleukin 1β (IL-1β)129. Canonical
inflammasome activity is a two-step process. In the first step, dubbed "priming”, pathogen- or
damage-associated molecular patterns (PAMP and DAMPs, respectively) signal through Toll-Like
Receptors (TLRs) leading to transcription factor NF-κB to translocate into the nucleus153,282.
Translocation leads to upregulation of inflammasome components, including NLRP3, pro-caspase
1, and the pro-form of IL-1β396. In the second step, “activation”, effectors cause assembly of NLRP3
with apoptosis-associate speck like protein containing caspase recruitment domain (ASC), and
procaspase-1 (itself cleaved to its mature form). The inflammasome then cleaves pro-IL-1β into its
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mature form for release through cleaved gasdermin D pore396 . Assembly of the NLRP3
inflammasome activation commonly requires K+ efflux294, but reactive oxygen species (ROS)17,
Cathepsin B (CatB)61 and direct P2X7R-NLRP3 interaction114 have also been implicated. P2X7R is
the most potent activator of the NLRP3 inflammasome114,129. P2X7R stimulation and downstream
inflammatory processes are complicated that merit in-depth examination.
P2X7R stimulation of cytokines is not limited to the IL-1 family. P2X7R stimulation alone is
sufficient to cause NF-κB translocation to the nucleus, and therefore act as its own “priming”
agent124,211 through direct interaction with myeloid differentiation primary-response protein 88
(MyD88), an adaptor protein for TLRs242. NF-κB signaling leads to transcription of a number of
cytokines more than simply the IL-1 family, including IL-6, IL-12, and TNF-α239 , and may regulate
production nitric oxide via nitric oxide synthetase118,297. Interestingly, NF-κB signaling appears to
be stimulus-specific, with DNA binding and gene expression (in epithelial cells)38, or NF-κB
monomer composition (in microglia cell lines)106 differing based upon the stimulus. Taken all
together, a full understanding of P2X7 receptor cytokine profile will elucidate specific inflammatory
effectors.
The benefits of P2X7 inflammatory response against a pathogenic insult are well
studied359. In contrast, the inflammatory response within the CNS generally contributes to
progression of chronic neurodegenerative diseases173. However, the effects of P2X7R stimulation
are context-dependent. P2X7R inhibition exacerbates negative effects in models of ischemia,
epilepsy, and Amyotrophic Lateral Sclerosis, or results in conflicting effects in Alzheimer’s disease
(AD) progression that are likely dependent on the mouse model194. Differential effects of receptor
antagonism can be attributed to the timing of intervention within the context of the disease, where
early inhibition of P2X7R increased microglial and astrocyte reactivity, and reduced motor
performance10, while later inhibits. But additional considerations must be made to signaling in
specific cell populations. P2X7R is widely expressed in many cell types, but at higher
concentrations in microglia189,395 where it is implicated in microglia neuroinflammatory processes3.
P2X7R has demonstrated protective effects specific to retinal ganglion cell populations of the
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eye233,421. A comprehensive understanding of P2X7R signaling need to incorporate time- and cellspecific outcomes into analyses.
1.3 Neuroinflammatory Glia in the CNS
Microglia. Microglia are the primary innate immune effector cells of the CNS. They
comprise 10-15% of all tissue cells within the CNS compartments220,283. Unlike other neural cell
populations which are derived from the neuroectoderm, microglia develop from erythromyeloid
progenitor cells that migrate from the yolk sac early in development198. Once established, microglia
adopt a ramified morphology and ‘scan’ the parenchymal environment with elongated
processes88,305, where they perform numerous functions to maintain homeostasis, including
phagocytosis of apoptotic cells, synaptic pruning, and facilitation of communication between
cells224,397. Microglia are long lived resident cells of the CNS, with region specific turnover between
8-41 months in mice117,219,407, and up to an average of 4.2 years in humans11,342. In health, neurons
themselves regulate microglia homeostasis with secretion of survival ligands such as interleukin34 (IL-34)134,311, or Transforming Growth Factor beta (TGF-β)35,54, a Colony-Stimulating 1 Factor
receptor (CSF1R) ligand100, or immunoquiescence-promoting factors such as Cx3CL178 and
CD20044,313. The phagocytic and neuroinflammatory functions that microglia perform are context
specific. In maintaining synaptic plasticity or promoting tissue repair259,361, they promote positive
outcomes. But in cases of neurodegenerative conditions, they can contribute to ongoing pathology
resolution, increased synaptic phagocytosis, or chronic inflammation92,130.
Microglia are morphologically plastic cells. In an immunoquiescent state, microglia extend
processes to synapses to surveil the environmental milieu88,305,358. Process ramification and
surveillance in the resting state is maintained by tonic activation of THIK-1 channels260, TAM
receptor tyrosine kinases113, and type-II myosin motors276. Upon exposure to PAMPs, DAMPs, or
cytokines, microglia undergo several cell state changes88,305,382, in a process referred to as
‘activation’

151

. Activation is accompanied by a diverse number of morphological and molecular

changes. Morphologically, microglia somas enlarge and processes retract and thicken, giving
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microglia a ‘bushy’ appearance

88,382

. Molecular changes, including cytokine secretion and

transcriptional changes follow morphological alteration88,308. Molecular alterations occurring late in
the process of activation involve upregulation of Ionized calcium binding adaptor molecule 1
(Iba1)176 and Cx3C chemokine receptor 1 (Cx3CR1) 64,133. Both proteins are expressed on microglia
and macrophage populations, and their upregulation are useful markers of inflammatory microglial
activation. Interestingly, downregulation of microglia identity markers, which distinguish CNSresident microglia from peripheral macrophage populations, are downregulated. P2Y12 is the major
chemotactic receptor responsible for migration towards sites of ATP, and is downregulated in a
timeframe long after its chemotactic role is fulfilled154. Transcriptional downregulation of identity
marker TMEM119 occurs in inflammatory conditions25. Although these markers fulfill diverse roles
in the physiology of the immune response, the assessment of these markers together provide a
useful understanding of the inflammatory environment.
Microglial activation have traditionally been divided into several states, simplified into
classical activation or M1 (M1), or alternative activation (M2)77. Classical activation is associated
with neuroinflammatory process, and polarization with response to PAMPs and DAMPs. Classical
activation effectors are varied, but include cytokines such as interferon gamma (IFNγ), which
signals via the STAT1 pathway leading to transcription of IRFs factors. Lipopolysaccharides (LPS),
which are bacterial components, lead to inflammation via signaling through Toll-Like Receptor 4
(TLR4), leading to NF-κB translocation into the nucleus and production of inflammatory molecules.
Gene and protein upregulation include several inflammatory cytokines, such as Interleukin 1β (IL1β), IL-6, Tumor Necrosis Factor (TNF), and redox molecules such as Nitrous Oxide (NO), with
similar genetic markers identifying cell state (e.g. Il1b, Il6, Tnfa, Nos2). Alternative activation (M2)
has traditionally been subdivided into subcategories itself. M2a alternative activation is entered with
chemokines IL-4 or IL-13 through the STAT6 signaling, and is associated with tissue repair and
regeneration. It is marked by canonical alternative activation markers Arginase 1 (Arg-1 with gene
expression of Arg1), YM1 (Chil3), and Insulin Growth Factor 1 (IGF-1). M2b is associated with
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immunomodulatory state with marked expression of IL-10 (Il10), while M2c is exemplified by
acquired deactivation, with expression of Versican Proteoglycan (VCAN/VCAN).
While these divisions offer useful indications of physiological responses by microglia,
developments since the implementation of these categorizations has pointed to the complexity of
microglia responses to environmental stimuli243,288,336. Inflammatory activation into a mixed
classical/alternative activation state has been found in several models103,292,336. Interestingly the
prototypical pro- and anti-inflammatory markers inducible nitrous oxide synthetase (INOS/NOS-2)
and Arg1, respectively, metabolize the same substrate, L-arginine289, and have been utilized as
prototypical pro- and anti-inflammatory markers. Elevation of arginine 1 had dampened the
elevation of Nos2 or release of redox species57,192. Microglia cell state is complex, and not
permanent, and microglia can exhibit a mix of classical and alternative activation gene
expression288, and the balance of pro- and anti-inflammatory gene expression can be altered with
external stimuli125. Close examination of gene expression remains a viable approach to
understanding inflammatory effects.
Astrocytes. They constitute up to 40% of all glial populations in the parenchyma158, yet care
must be taken as they constitute a heterogeneous population363. Astrocytes maintain homeostasis
by regulating extracellular glutamine, neurotransmitters, and ion concentrations72,376. As with
microglia, positive or negative contributions to neurodegeneration are context-dependent. Recent
work has pointed to astrocyte as contributors to neurotoxicity when activated by cytokines TNF-α,
IL-1α, and C1q145,231,232. Modeled on traditional definitions of microglial cell state, these A1
neurotoxic are transcriptionally defined by gene expression from lipopolysaccharides (LPS) 444. A1
astrocytes have been observed in post-mortem tissue from patients with Huntington’s disease
(HD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), and AD

231

. However, the

mechanism of neurotoxicity remains unknown. Regardless, induction into A1 neuroinflammatory
state reduced neural synapse formation using in vitro cocultures231. Upstream mediators leading to
A1 astrocyte polarization are understudied, and remain an interesting avenue of research. Inhibition
of A1 astrocyte conversion with exposure to a glucagon-like peptide-1 receptor (GLP1R) was
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observed in vivo in a model of glaucoma383, and in vivo and in vitro in models of exposure to PD
protein alpha-synuclein442. As P2X7R stimulation induces secretion of TNF-α and IL-1α from
microglia155,370, microglial P2X7R presents a lucrative target for amelioration of A1-astrocyte
response.
The definitions of A2 astrocytes are derived from gene expression444 and expression of
trophic factors128. A2 astrocyte functions have been identified primarily from analysis of ischemia128,
where A2 astrocytes are characterized by secretion of growth-promoting factors. Viral knockdown
of protein deglycase DJ-1 after transient middle cerebral artery occlusion (tMCAO) reduced neuron
survival, putatively via prevention of astrocyte Nfr2 translocation to the nucleus and subsequent
reduction of glutathione secretion321. Astrocytes exposed to factors from bone-marrow replacement
with Bone Marrow Stromal Cells (rBMSCs) then subsequently subjected to ischemia showed
elevated expression of Brain-Derived Neurotrophic Factor (BDNF), basic fibroblast growth factor
(bFGF), and vascular endothelial growth factor (VEGF)121, thus the insinuating that exposure to
rBMSCs induce A2 reactive astrocytes230.
As with microglia, clear delineations of “pro-inflammatory A1” versus “neuroprotective A2”
are simplistic, but useful models of more complex phenomena128,230. RNA sequencing has identified
five subpopulations of astrocytes within the CNS that were not regionally specific186. Furthermore,
transcriptional diversity was observed even within layers of the cerebral cortex18. Astrocyte
reactivity is currently being redefined to address pathology-specific cell ‘states’ but currently
remains a tool to understand neuroinflammatory environment101.
In the CNS, neurotoxic A1 astrocytes are induced with proinflammatory cytokines tumor
necrosis factor alpha (TNF-α), interleukin 1 alpha (IL-1α), and complement component C1q231.
Specific origin of these factors has not been explored adequately, but microglia are hypothesized
to be the likely candidates for expression of these factors230. Microglia exposed to LPS in co-culture
models do express these factors, and subsequent exposure of cultured astrocytes to conditioned
media containing the factors resulted in polarization towards an A1 phenotype231. Within the CNS,
TNF-α330, C1q47, and IL-1α15 are all primarily expressed or induced by microglia. However, ablation

8

of microglia failed to preserve loss of retinal neural populations after injury, as part of the work that
popularized neurotoxic astrocyte mediated inflammation231. Although microglia likely play a large
role in production of factors that induce neurotoxic astrocytes232 origins of these cytokines should
be confirmed. Moreover, the triggers which initiate the release of these components from microglia,
and ultimately promote the astrocyte response, are unclear.
1.4 Inflammation in glaucoma and models of elevated retinal pressure
The retina is an “outpouching” of the CNS that functions to translate light entering the eye
into neural signals135. It is organized into several discrete synaptic layers supported physically and
metabolically by glial populations, with photoreceptors and epithelial cells comprising the outermost
layer of the retina (Figure 1.2). Photoreceptors synapse on bipolar and horizontal cells at the Outer
Plexiform Layer (OPL) to transmit light signals received on photoreceptors into neural signals.
Bipolar cells act as interneurons, and synapse on Retinal Ganglion Cells (RGCs) at the Inner
Plexiform Layer (IPL). Retinal ganglion cells (RGCs) are the primary neuronal populations of the
retina. Their nuclei define the Retinal Ganglion Cell Layer (RGCL/GCL). With Müller Glia, RGC
axons comprise the Nerve Fiber Layer (NFL) as axon tracts are directed to the optic nerve166.
There exist three major populations of glial cells of the retina. Retinal astrocytes and Müller glia
constitute macroglial populations, and microglia339 (Figure 1.2). Retinal astrocytes are located at
the NFL and the RGCL. Müller glia span the retina between the ONL and the NFL, and are the
primary glial population of the retina339. Müller glia and astrocytes perform many of the same
functions within the retina (with Müller glia acting as main homeostatic effectors), including recycling
of neurotransmitters, ion buffering, and clearance of water that may accumulate with ion
accumulation or temporary imbalances of vitreal fluid flow339.
Microglia perform similar roles in the retina as the CNS by maintaining synaptic
homeostasis, phagocytosing dead cells, and responding to environmental stimuli with inflammatory
effectors In the healthy, mature retina, microglia are uniformly spaced. tiling the planes of the
RGCL, IPL, and OPL355. Retinal microglia also exhibit slow turnover257,310, a feature which may
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A

Figure 1.2. Structure of the retina. A Vertical diagram of a retina depicting layers. From the
top. Left depicts the location of the major glial populations and the layers they reside in. AST:
astrocyte, MG: microglia, M: Müller cell.
contribute to age-related inflammation256. Distribution in the RGCL, IPL, and OPL allow microglia
dynamic contact with axonal, dendritic, and synaptic compartments of neurons374. microglia
homeostatic function in the healthy retina is relatively understudied, but roles are similar to those
in the CNS, in that they maintain synaptic health and phagocytose apoptotic cells374. Chronic
ablation of microglia for thirty days led to altered responses to light and increased synaptic
degeneration425, confirming that microglia play an active role in healthy retinae.
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Glaucoma. Glaucoma is a progressive retinal degenerative disease that affected nearly 80
million people by 2020375,428. In the United States and Europe, the majority of cases consist of
Primary Open Angle Glaucoma (POAG) whereby the drainage angle of the trabecular meshwork
remains open428. POAG patients can suffer from irreversible vision loss, with some patients
suffering complete blindness428. The major risk factors for onset of glaucoma are age, elevated
intraocular pressure (IOP), and a thin cornea334, with conventional definition of elevated IOP as
being greater than 21 mm Hg428. IOP elevation is caused by increased production of aqueous
humor or decreased outflow through the trabecular meshwork at the anterior chamber of the eye380
(Figure 1.3). Onset of elevated IOP can occur years or decades prior to measurable loss of visual
function428, suggesting a link between pressure and retinal damage. Current treatments focus on
lowering IOP with surgical intervention or therapeutic eye drops, but disease progression can
continue even when patients maintain normal IOP136,156,333. The processes connecting elevated
pressure at the anterior of the eye connecting to RGC damage at the posterior of the eye are
unclear. Several pathogenic factors have been suggested to contribute to glaucomatic progression,
such as elevated glutamate levels, ischemic events, oxidative stress, and immune activation415, but
further study is merited.
ATP has been found in the aqueous humor of patients suffering from Primary Acute Angle
Closed Glaucoma (PAACG)448 and Primary Chronic Angle Closed Glaucoma (PCACG)223, in
addition to POAG332. In the instances of PAACG and PCACG, elevated ATP levels correlated to
elevation of IOP223,448. Increased ATP was detected in Rat, Mouse, and Primate eyes after elevation
of IOP. Also, loss of RGCs observed in the episcleral vein scarring model of chronic IOP elevation
in rats and the genetic mouse models250. Altogether, this indicates that purinergic signaling may
link elevated IOP to RGC damage.
Measurement of the effects of mechanical strain in glaucoma are driven by a number of
rodent model systems, with accompanying strengths and weaknesses. The most common genetic
model in use is the DBA/2J inbred model, whereby onset of IOP elevations occur at 7-9 months
resulting from iris atrophy229 The DBA/2J is a useful model to study the effects of chronic elevated
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IOP and subsequent loss of RGCs. However, IOP elevations were inconsistent and noninvasive
tonometry measurements were complicated by corneal calcification416. Additionally, about 20% of
the mice develop major complications, which result in high rate of omission from data analysis416,

Figure 1.3. The eye in health and disease. A In a healthy eye, fluid from the anterior chamber
flows out via the trabecular meshwork. B In a glaucomatic eye, fluid outflow via the trabecular
meshwork is reduced, resulting in elevated pressure within the eye. The elevated mechanical
strain leads to release of ATP from cells of the retina.
casting doubt on the utility of the model. In non-transgenic models, IOP elevations can be achieved
for days to weeks through mechanical manipulation of outflow. Increasing outflow resistance
through episcleral vein cauterization (EVC) or injection of hypertonic solution resulting in elevated
IOP within a week and lasting up to several weeks, with moderate variability of IOP elevation among
subjects87,291,368. Scleral damage is common with cauterization, complicating the phenotypic
results349. Though less technically demanding than EVC, hypertonic saline injection requires
weekly or biweekly injections to maintain elevated IOP274. Success at manipulating outflow with
less injury has been found with injection of magnetic microbeads to block the trabecular
meshwork352,356. As with hypertonic saline injection, a second injection is often required to sustain
elevation of IOP after several weeks. Optic nerve crush (ONC) is an invasive model to replicate
RGC loss without elevation of IOP364. Data presented in this dissertation relies upon cannulation of
the anterior chamber of the eye as an acute model of elevated IOP. Within the model, the fluid
pressure into the anterior of the eye is precisely controlled by a reservoir attached to the cannulating
needle. Only this model of cannulation provided for precise control over the pressure and timing of
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the IOP. Understanding the effects of elevated pressure on inflammation and RGCs is strengthened
when data are supported in multiple models.
Glaucoma and P2X7R. The mechanical strain associated with elevated IOP is a likely
candidate for extracellular ATP release 50,398. ATP has been found to be released from a variety of
cell types via sheer stress50, distention of tissue207, and cell swelling280. Mechanosensitive pannexin
hemichannels are implicated in ATP release20,341,433.

Likewise, the existence of ATP in

glaucomatous patients suggests a role for purinergic receptors in progression of retinal damage
from mechanical strain. As such, the P2X7 receptor represents an ideal target to study negative
downstream effects from strain. In the DBA/2J genetic mouse model, elevated gene and protein
expression of the P2X7 receptor was observed at 3 months (compared to C57Bl/6J counterparts),
with elevation further increased at 15 months218,323. This mouse model additionally demonstrated
reduced RGC synaptic organization and retinal function323. Topical allosteric P2X7R antagonist
JNJ4795567 was chronically applied to this model, and led to preservation of RGC number and
function at 38 weeks of age346 Elevation of IOP in the rat EVC model of chronic ocular hypertension
resulted in elevated Iba1 levels of microglia and moderate loss of RGCs within one week, which
was inhibited by administration of P2X7 receptor orthosteric antagonist Brilliant Blue G (BBG)94.
Similar observations were made elsewhere, with acute elevation of IOP in rats to ischemic levels.
Elevated IOP led to loss of RGCs in rats, which was prevented by coadministration of orthosteric
antagonists BBG and Oxidized ATP (OxATP) in a dose-dependent manner392. Additionally, direct
administration of P2X7R-selective agonist BzATP to the retina has led resulted in the loss of RGCs
in rats94 and mice168.
Interestingly, P2X7R stimulation in these models has demonstrated some benefits.
Transient elevation of IOP reduces function of the subpopulation of RGCs that respond to
decreases in light intensity (OFF-RGCs)354,421. However, retinae derived from P2X7R-/- subjected
to elevated IOP demonstrated an additional reduction of light-evoked responses in RGCs that
respond to increases in light intensity (ON-RGCs)421. Isolated primary mouse RGCs that were
subjected to strain or stimulated with BzATP secreted Inteleukin-3 (IL-3) more than other
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cytokines233. IL-3 promotes neuron survival

233,254,445

. Finally, Interleukin-6 (IL-6) was elevated in

whole retinae after transient IOP elevation, as well as in vitro primary retinal astrocytes following
application of mechanical strain or hypotonic solution, inhibited with BBG6. IL-6 frequently acts as
a neuroprotective, especially when signaling via the membrane-bound form of the IL-6 receptor348.
Glaucoma and Microglia. Mounting evidence supports a role for neuroinflammation in
glaucoma409. In human patients, antibody titers against heat shock proteins (HSPs), myelin basic
protein, GFAP, and vimentin were detected in the aqueous humor of the eye (reviewed in Tsai et
al., 2019415). Furthermore, elevated complement proteins were detected in the retinae and sera of
POAG patients34,410. Immunohistochemical analysis of human glaucomatous patient samples has
detected elevated expression of TNF-α, COX-2, and NOS2 colocalizing with microglia440, as well
as elevated GFAP immunoreacitvity423. Furthermore, human glaucomatous tissue revealed
upregulation of Toll-like Receptors (TLRs) -2, -3, -4 in Iba1+ microglia and GFAP+ astrocytes/Müller
cells253. TLRs are broad pathogen-sensing receptors that induce inflammatory responses399. The
specific components of neuroinflammation remain to be studied.
As the primary innate immune cells of the retina, microglia likely contribute to disease
progression427. Morphological alterations in microglia in concert with activation peaked at 3 months
of age, prior to loss of RGCs the DBA/2J mouse model of chronic elevated IOP

42

. Microglia

activation at 6 weeks preceding loss of RGCs at 15 weeks was observed in rats whose IOP was
elevated using chondroitin sulfate (CS)37. In rats where IOP was elevated with ECV, whole retinae
subjected to elevated IOP expressed increased content of oxidation proteins NOS2 and NADPH
oxidase-4 (NOX4), and increased translocation of NF-κB p65 subunit into the nuclear fraction171.
In a mouse model of elevated IOP that was induced by laser irradiation, expression of protein TNFα was upregulated296. Neutralization of TNF-α with antibodies or genetic knockout mouse models
reduced loss of RGCs and oligodendrocytes at the optic nerve head. A study in rats utilizing
episcleral vein blockage to elevate IOP determined that TNF-α was expressed only in microglia
and Müller cells84 Interestingly, loss of RGCs was also reduced in mice where complement receptor
3 (CR3, previously Mac-1) was deleted296, pointing to the role of complement factors in loss of
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RGCs. Cytokine elevation is an early event in progression of pathology in the DBA/2J model.
Retinae were found to have significant upregulation of inflammatory mediators such as IL-1β, IL6, and TNF-α prior to 5 months431. However, anti-inflammatory mediators IL-10 and IL-5 were also
detected431, indicating that the contributions that inflammation makes to RGC loss may be a
balance, rather than a binary switch. An understanding of compensatory neuroprotective
mechanisms will elucidate specific mechanisms leading to RGC death324.
Activation itself may be a contributing factor, possibly through increased phagocytosis45.
Deprived of immunoquiescent signaling via Cx3CR1, microglia were found to phagocytose healthy
RGCs and at-risk photoreceptors in a mouse model of Retinitis Pigmentosa443. Stimulation of
microglial immunoquiescent receptor Cx3CR1 has been demonstrated to reduce microglial
activation422,443. Deletion of the receptor resulted in a greater loss of RGCs after transient elevation
of IOP422, and increased cytokine secretion and phagocytosis of photoreceptor material in the Rd1
mouse model of Retinitis Pigmentosa443. Inhibition of activation with antibiotic minocycline after
elevation of IOP422 or in the DBA/2J chronic IOP model40 reduced RGC loss as well, indicating that
activation-mediated phagocytosis plays a role.
Microglia depletion in models of elevated IOP can offer insights regarding the role of
microglia in disease progression. However, data were found in only one study utilizing the ONC
model. Microglia depletion using PLX5622 had little effect on neural degeneration or axonal
regeneration160. In other retinal disease models, microglia depletion has demonstrated diverse
outcomes, but roughly falling in line with putative neuroinflammatory or phagocytic roles that
microglia inhabit. An alteration of inflammatory marker expression (but not a reduction), as well as
loss of RGCs was observed two months after depletion of microglia with subsequent optic burn,
with evidence pointing to inflammatory peripheral monocyte engraftment and adoption of microglia
morphology318,319. Similar migration and engraftment was observed two months after acute
elevation of IOP without depletion as well318. Ablation of microglia in the retinal vein occlusion model
of retinal ischemia reduced inflammation and preserved RGCs187. In the RhoP23H model of retinitis
pigmentosa, where retinal degeneration occurs from excessive light damage (LD), microglia
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depletion via diphtheria toxin (DT) resulted in accumulation in photoreceptor debris and worse
retinal damage than their non-depleted counterparts311. A comprehensive analysis of early
microglial signaling in elevation of IOP still needs to be determined.
Glaucoma, astrocytes, and Müller glia. Onset of POAG is associated with polymorphisms
of TNF43 and IL1A285. Human patient samples revealed upregulated protein expression of TNF441
and C1q381, all associated with astrocyte neurotoxicity231. In a model of chronic elevated IOP
induced with bead blockage of aqueous outflow, genes associated with neurotoxic A1 astrocytes
were detected145,383. Furthermore, gene expression elevation was found specific to macroglial
populations in the retina383. In both cases, inflammatory gene upregulation was not observed in
retinae from mice where Tnfa, Il1a, and C1qa were ablated145,383. Together this indicates the
primary inflammatory role that macroglia play in loss of RGCs from elevated IOP. Reactive GFAP+
astrocytes/Múller glia mediate neuroprotective roles after elevation of IOP. Genetic ablation of
astrocyte transcription factor signal transducer and activator of transcription 3 (STAT3) which
activates downstream of ligands such as interferons, epidermal growth factor, and IL-6161 resulted
in an attenuation of astrocyte activation, greater loss of RGCs and greater visual dysfunction after
several models of elevated IOP393.
Indicators of reduced of oxygenation in cells, a process termed hypoxia, colocalize with
Müller glia 4 weeks after elevation of IOP with the bead model, likely reducing glial antioxidant
support of RGCs
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likely reducing glial antioxidant and neuroprotective factors182. Müller glia

additionally contribute to production of excitotoxic factors449. Astrocytes in mechanical strain
models proliferated near the optic nerve in the DBA/2J model79, as well as upregulated components
in the NLRP3 inflammasome following transient IOP elevation6. The contributions of macroglial
populations to progression of damage from elevated IOP are complex, and merit close study.
1.5 Phagocytosis and Autophagy
P2X7Rs make a critical contribution to the clearance functions of microglia, in addition to
their effects on inflammatory signals in the cells. Data are emerging that P2X7R influences major

16

microglial functions associated with clearance of extracellular debris. P2X7R influences
phagocytosis both by acting as a scavenger receptor, and influencing phagocytic receptor
expression via inflammatory processes. Additionally P2X7R-mediated promotion or inhibition of
autophagy is time- and context-specific, while autophagy regulates P2X7R inflammation
mechanisms60,314.
The process of microglial phagocytosis can be categorized into discrete steps328. First,
pruned synapses, apoptotic cells, or debris are recognized and bind to phagocytic receptors on the
surface of the host cell109. Microglia express a diverse profile of phagocytic receptors, such as
pattern recognition receptors (PRRS), like TLRs or Scavenger Receptors, or opsonic receptors,
such as CD45 or CD11b. Second, cytoskeletal actin rearrangement promotes formation of the
phagocytic cup for engulfment of the target. Third, the material is shuttled via the ESCRT system
through the phagosome, which matures into a late endosome, then fuses with the lysosome
(forming a phagolysosome) for degradation. Finally, degraded material is recycled, while content
influences cell response through gene transcription. Additionally, material that comprised the
endosome is recycled back to the plasma membrane fuses with the trans-Golgi network (TGN)377.
In contrast to processes that degrade extracellular components, the process of autophagy
degrades intracellular components to maintain internal homeostasis and for purposes of recycling.
The most studied autophagic process, whereby cargo is taken into vesicles away from the
lysosome, is known as macroautophagy (herein: autophagy). The process of autophagy is complex
and multifactorial, usually broken into several steps317,327. Initiation of autophagy usually begins
with inhibition of Mechanistic Target of Rapamycin Complex 1 (mTORC1)235, which disinhibits
formation of Autophagy-related (Atg) 1/13/17/31/29 kinase complex (in yeast) or the Unc-51-like
(ULK1) kinase complex (in humans). Subsequently, recruitment of the beclin-1/vacuolar protein
sorting 34 (BECN-1/Vps34) complex to catalyze the formation phosphatidyl-inositol-3-phosphate
(PI3P) participates in ‘nucleation’ of phagophore formation306. Following initiation, in ‘elongation’,
the double-membraned structure involves the lipidation of microtubule-associated light chain 3
(LC3) with phosphatidylethanolamine (PE)317, a transition denoted by the change from LC3-I to
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LC3-II206. Thus the autophagosome is formed. Next, the autophagosome is merges with a
lysosome to create the autolysosome317. with GTPase Ras-related protein RAB7177, SNAP
Receptor (SNARE) proteins175, and lysosome ion channel signaling270,271 all implicated in fusion.
Autophagy is regulated by energy and nutrient sensing. mTORC1 is inhibited in an environment of
low amino acids, thereby initiating autophagy452. Additionally, a combination of low intracellular ATP
and high intracellular adenosine monophosphate (AMP) activate AMP-activated protein kinase
(AMPK), which inhibits mTORC1317.
Disruptions in autophagy and phagocytic play a role in microglia signaling in
neurodegenerative conditions188,327,328,377. In aging, myelin350 and lipid droplets266 accumulate in
microglia and contribute to expression of Major Histocompatibility Complex II (MHCII) proteins350,
and reactive oxygen species (ROS) generation58, respectively. While the influence of
autophagic/phagocytic pathways is unclear in age, autophagic machinery is known to participate
in phagocytosis and degradation of materials in proteinopathies327. with reduction of uptake
observed in vitro In mouse models of Parkinson’s disease inclusions of alpha-synuclein (α-syn)405,
parenchymal deposition of which is elevated by deletion of Atg7 and influenced by lipid
metabolism436. Incomplete phagocytosis of amyloid-beta (Aβ) deposits contribute to “microglia
exhaustion” and release of neuroinflammatory factors388,389. Microglia from human AD patients
show reduced beclin 1 protein levels, with knockdown of the gene in vitro or in hippocampal brain
slices revealing reduced Aβ uptake and recycling of phagocytic receptor Trem2 protein252.
P2X7R influences over autophagy are diverse, with autophagic induction with transient
stimulation, while evidence points to P2X7R negatively regulating autophagy with chronic
stimulation. Within cultured microglia, P2X7R stimulation has demonstrated to elevate ratios of
LC3-II compared to LC3-I, likely through induction of autophagy103,402. Yet transient stimulation has
also demonstrated aberrant endolysosomal secretion of lysosome-derived degradative enzyme
cathepsin D (CatD) into the extracellular space401,402, while prolonged stimulation leads to elevation
of pHLys in primary microglia402 and microglial cell lines365. In astrocytes, P2X7R deletion led to
upregulation of heat shock protein B1 (HSPB1) and induction of autophagy via mTOR-independent
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pathways203. In models of osteoarthritis, P2X7R stimulation led to induction of autophagy factors
Beclin-1 and LC3B within weeks, whereas prolonged stimulation led to upregulation of mTOR and
inhibition of autophagy, eventually leading to cell death226. It is likely that P2X7R stimulation affects
autophagy in a time-dependent and cell-specific manner.
Within microglia, autophagy plays a large role in degrading P2X7R-mediated inflammatory
components. Elevated autophagy is associated with decreased NLRP3 inflammasome function in
vivo63 and in vitro63,68,150,438 in microglia. Similarly, components of the NLRP3 inflammasome
colocalize ASC369 or IL-1β152 with autophagic or lysosomal markers, indicative of autophagicmediated degradation. Administration of rapamycin to microglia reduced IL-1β protein and Iba1
immunoreactivity (emblematic of activation) that was brought on in a model of chronic migraine183.
A more granular understanding of the P2X7R intracellular crosstalk among phagocytosis,
autophagy, and lysosome signaling will offer new insight into influencing inflammation.
Furthermore, the influence of inflammatory mechanisms on autophagy are unclear. The role of
P2X7R and associated inflammatory mechanisms and the complex crosstalk with the microglial
endolysosomal system is explored in Chapter 4.
1.6 Dissertation goals
The research described in this dissertation is focused on the role of the P2X7 receptor in
microglial activation and microglia inflammatory effects. Work presented here utilized in vitro cell
culture manipulations and in vivo retinal injections and a model of mechanical strain, whereby
intraocular pressure was exogenously increased. Since the contributions that microglial activation
and P2X7R-mediated inflammation make to loss of retinal ganglion cell populations remain
understudied, a comprehensive understanding of P2X7R effects can lead to more specific
therapies to inhibit negative effects arising from P2X7R signaling, while preserving any positive
effects. Additionally, a specific understanding of P2X7R effects on microglial phagocytosis and
autophagy had not been completed. As such, the goals of this dissertation were to 1) Determine
the detailed morphological and molecular effects of direct stimulation of P2X7R on microglial cells
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in vitro and in vivo, and explore the receptor contribution upon IOP elevation; 2) explore the role of
P2X7R in microglial/astrocyte activation pathways and 3) describe the roles of P2X7R in autophagy
and phagocytosis by microglial cells. We find that P2X7R acts as a key regulator or microglial
activation, inflammation, phagocytosis, and astrocyte reactivity.
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CHAPTER 2: RAPID MORPHOLOGIC CHANGES TO MICROGLIAL CELLS AND
UPREGULATION OF MIXED MICROGLIAL ACTIVATION STATE MARKERS INDUCED BY
P2X7 RECEPTOR STIMULATION AND INCREASED INTRAOCULAR PRESSURE *
2.1 Abstract*
The identification of endogenous signals that lead to microglial activation is a key step in
understanding neuroinflammatory cascades. As ATP release accompanies mechanical strain to
neural tissue, and as the P2X7 receptor (P2X7R) for ATP is expressed on microglial cells, we
examined the morphological and molecular consequences of P2X7 receptor stimulation in vivo and
in vitro and investigated the contribution of the P2X7 receptor in a model of increased intraocular
pressure (IOP). In vivo experiments involved intravitreal injections and both transient and sustained
elevation of IOP. In vitro experiments were performed on isolated mouse retinal and brain microglial
cells. Morphological changes were quantified in vivo using Sholl analysis. Expression of mRNA for
M1 and M2-like genes was determined with qPCR. The luciferin/luciferase assay quantified retinal
ATP release while fura-2 indicated cytoplasmic calcium. Microglial migration was monitored with a
Boyden chamber. Sholl analysis of Iba1-stained cells showed retraction of microglial ramifications
one day after injection of P2X7R agonist BzATP into mouse retinae. Mean branch length of
ramifications also decreased, while cell body size and expression of Nos2, Tnfa, Arg1, and Chil3
mRNA increased. BzATP induced similar morphological changes in ex vivo tissue isolated from
Cx3CR1+/GFP mice, suggesting recruitment of external cells was unnecessary. Primary microglial
cultures expressed P2X7R; elevation of cellular Ca2+ by BzATP and block by antagonist A839977
provided functional confirmation. BzATP induced process retraction and cell body enlargement
within minutes in isolated microglial cells, and increased Nos2 and Arg1. While ATP increased

*

Some text and figures taken or modified from Campagno KE, Lu W, Jassim AH, Albalawi F,
Cenaj A, Tso HY, Clark SP, Sripinun P, Gómez NM, Mitchell CH. Rapid morphologic changes to
microglial cells and upregulation of mixed microglial activation state markers induced by P2X7
receptor stimulation and increased intraocular pressure. (2021) J Neuroinflammation 18(1):217.
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microglial migration, this required P2Y12R, not P2X7R. Transient elevation of IOP increased retinal
ATP release and microglial process retraction, cell body enlargement and gene upregulation
paralleling changes with BzATP injection. Pressure-dependent changes were reduced in P2X7-/mice. Death of retinal ganglion cells accompanied increased IOP in C57Bl/6J, but not P2X7-/- mice,
and neuronal loss showed some association to microglial activation. P2X7R stimulation induced
rapid morphological activation of microglial cells, including process retraction and cell body
enlargement, and upregulation of markers linked to both M1 and M2-type activation. Parallel
responses accompanied IOP elevation, suggesting ATP release and P2X7R stimulation influence
the early microglial response to rising pressure.
2.2 Introduction
The contribution of microglial cells to neural damage is complex, and untangling
interactions between stimuli, cell types, and signaling cascades requires a detailed analysis

55

.

Microglial cells are resident immune cells in neural tissue responsible for synaptic maintenance
and the innate immune response to injury or microbial infiltration
beneficial in their immunoquiescent M0 state

397

76,351

. While considered largely

, microglial dysregulation is implicated in several

neuroinflammatory pathologies 42,53,269, including diseases that involve mechanical strain to neural
tissue, such as traumatic brain injury, cerebral edema and glaucoma 93,122,170,335. Identifying signals
that link mechanical strain to microglial activation could help reduce the destructive
neuroinflammation associated with these disorders.
The release of ATP is a widespread response to mechanical strain found throughout the
body, including in neural tissue

20,81,426

. The released ATP stimulates ionotropic P2X or

metabotropic P2Y receptors, and can act at adenosine receptors after dephosphorylation

417

.

Inflammatory responses are most frequently associated with the P2X7 receptor, and stimulation by
ATP can lead to activation of the NLRP3 inflammasome and release of various cytokines linked to
neural inflammation 3,359. P2X7 receptors are emerging as important regulators of microglial cells,
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with in vitro experiments in murine microglial cells showing that receptor stimulation leads to release
of the IL-1 family cytokines, caspase 1 cleavage and altered phagocytosis 155,179.
The mechanical strain accompanying the elevation of intraocular pressure (IOP) is
associated with both ATP release

223,250,344

, and microglial activation

41,181,441

. The P2X7 receptor

has been implicated in increased staining for microglial markers CD68 392 or Iba1 94 following IOP
elevation, but details of the molecular and morphological changes induced in microglial cells by
P2X7 receptor stimulation following IOP elevation, and the timing of such responses, remain
unclear. In this regard, the particular type of activation state induced in microglial cells by P2X7
receptor stimulation is of particular relevance, as the classical activation state (M1) is traditionally
defined by release of proinflammatory cytokines or neurotoxic effectors that exacerbate
neurotoxicity

33,67,146

, while the alternative activation states (M2) promote phagocytosis and waste

clearance, neurogenesis, axon remodeling, or remyelination after an injury 119,169,241. As microglial
activation states are now recognized to be more fluid and less binary than suggested by the
traditional M1 and M2 classifications

312,336

, a more nuanced understanding of how stimuli modify

the morphological and molecular response of microglial cells is needed.
This study provides a detailed analysis of the molecular and morphologic consequences
of P2X7 receptor stimulation in microglia cells in vitro and in vivo. The ability of receptor stimulation
to trigger process retraction and migration was probed, and effects on markers for M1 and M2
activation states were examined. Receptor stimulation was examined in a more relevant
pathophysiological context by elevating IOP. The relationship between IOP elevation, microglial
activation and death of retinal ganglion cells was also investigated. The findings confirm a central
role for the P2X7 receptor in the early activation of microglial cells following pressure elevation.
2.3 Materials and Methods
Animal care and use: All procedures were performed in strict accordance with the National
Research Council’s “Guide for the Care and Use of Laboratory Animals” and were approved by the
University of Pennsylvania Institutional Animal Care and Use Committee (IACUC) in protocol
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#803584. All animals were housed in temperature-controlled rooms on a 12:12 light:dark cycle with
food and water ad libitum. Mice were obtained from Jackson Laboratories (Bar Harbor, ME).
B6.129P2(Cg)-CX3CR1tm1Litt/J mice were bred with C57BL/6J mice for pups that were heterozygous
for GFP expression on the CX3CR1 promoter (CX3CR1+/GFP). Though microglia derived from
CX3CR1+/GFP mice have an altered transcriptome

147

and measured physiological responses

differences likely represent a more aged phenotype

147
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,

, and not a physiologically irrelevant

response.
Intravitreal injections Intravitreal injections were performed as previously described 168. Briefly, after
mice were anesthetized with 1.5% isofluorane, 1.5 μl Sterile Balanced Saline solution or 250 μM
Benzoylbenzoyl-ATP (BzATP; Sigma Aldrich) was injected into the superior nasal region of the
vitreous cavity approximately 0.5 mm from the limbus with a micropipette attached to a
microsyringe (Drummond Scientific Co.). Animals were excluded if the lens was damaged.
Differences in gene expression between saline-injected and naïve retinae from litter-controlled
mates were not significant.
Retinal imaging: Dissected retinae were nicked to preserve orientation after sacrificed and
enucleation. Retinae were fixed in 4% paraformaldehyde for 20 min, incubated with 0.1% Triton X100 (Sigma-Aldrich) in SuperBlock buffer (ThermoFisher) for 30 min at 25°C, then 10% goat serum
in SuperBlock for 1 hr. Retinal whole mounts or sections were incubated with primary antibodies
18-48 hrs at 4°C, with secondary antibodies for 60 min at 25°C, then mounted with SlowFade Gold
anti-fade mounting medium (Molecular Probes). Antibodies are listed in Table 2.1. For ex vivo
experiments, CX3CR1+/GFP mice were euthanized by CO2 and enucleated eyes placed into isotonic
solution (consisting of (in mM) 105 NaCl, 5 KCl, 6 4-(2-hydroxyethyl)-1-piperazineethanesulfonic
(HEPES) acid, 4 Na 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, 5 NaHCO3, 60 mannitol,
5 glucose, 0.5 MgCl2 and 1.3 CaCl2, pH 7.4) with or without BzATP and imaged on a Nikon A1R
microscope of the University of Pennsylvania Live Cell Imaging Core. Retinal whole mounts were
dissected as previously described

168

. Following exposure to BzATP or isotonic solution for 2 hrs
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Table 2.1: Antibodies used for immunofluorescent staining
Antibody
Source
Identifier
Dilution
Primary Antibodies

Use

Anti-Brn-3a

Santa Cruz

sc-31984

1:250

Whole mounts

Anti-Iba1

Chemicon

MAB360

1:500

Immunocytochemistry

Anti-GFAP

Wako

019-19741

1:500

Anti-Iba1

Abcam

AB48004

1:200

Whole mounts,
Cryosections,
Immunocytochemistry
Immunocytochemistry

Anti-P2X7 Receptor

Alomone

APR-008

1:200

Immunocytochemistry

Anti-Synaptophysin

Thermo Fisher

MA5-14532

1:250

Immunocytochemistry

Anti-Mouse Alexa Fluor 488

Thermo Fisher

A21202

1:500

Whole mounts

Anti-Rabbit Alexa Fluor 488

Thermo Fisher

A21206

1:500

Immunocytochemistry

Anti-Mouse Alexa Fluor 488

Thermo Fisher

A11001

1:500

Immunocytochemistry

Anti-Goat Alexa Fluor 488

Thermo Fisher

A11055

1:500

Immunocytochemistry

Anti-Rabbit Alexa Fluor 546

Thermo Fisher

A11035

1:500

Immunocytochemistry

Anti-Goat Alexa Fluor 555

Thermo Fisher

A21432

1:500

Immunocytochemistry

Anti-Rabbit Alexa Fluor 555

Thermo Fisher

A31572

1:500

Anti-Goat Alexa Fluor 555

Thermo Fisher

A10042

1:500

Whole mounts,
Immunocytochemistry
Immunocytochemistry

Secondary Antibodies

at 37° C, retinae were fixed with 4% PFA for 15 minutes at 25°C and mounted using SlowFade
Gold medium (ThermoFisher).
Image analysis: Z-stacks were acquired from retinal whole mounts with a TCS SP8 confocal
microscope (Leica). Iba1+ cells of the Retinal Ganglion Cell (RGC) and Inner Plexiform (IPL) layers
were counted using FIJI
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and randomized (www.randomizer.org). Fluorescence intensity was

determined in a 5 μM radius of the nucleus center. Sholl analysis/summed branch length was
performed outside of this radius using the FIJI Simple Neurite Tracer (SNT) plugin 245.
Observer quantification of morphological alterations: Retinal whole mount images were acquired
from the central, middle, and peripheral regions of the retina as defined above using a Nikon Eclipse
microscope (Nikon), with each region taken at the superior, nasal, inferior, and temporal quadrants.
De-identified images were scored individually based upon morphology. Smaller cell body size and
elongated, thin processes received a score of 1, larger body size and short, thick processes
received a score of 3 (Fig. S2a). Observer scores of BzATP-exposed retinae correlated to Iba1-
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intensity of the soma region (Fig. S2b), and there was close agreement among observers, with the
standard deviation of the scores between observers being less than 15% of the mean across all
regions, validating the approach.
Quantitative PCR: Retinae or isolated microglia were homogenized using TRIzol (Invitrogen). RNA
was purified with an RNeasy mini kit (Qiagen, Inc.) and converted to cDNA using a High Capacity
cDNA Reverse Transcription Kit (Applied Biosystems); qPCR was performed with Power or
PowerUp SYBR green (Applied Biosystems) on the 7300 or Quant Studio 3 Real-Time PCR
systems (Applied Biosystems) using standard annealing and elongation protocols, with data
analyzed using the delta-delta CT approach as described 247. Primers are listed in Table 2.2.
Table 2.2: Primers used for qPCR
Gene name
Genbank accession
Nos2
NM_010927.4
Tnfa

NM_013693.3

Arg1

NM_007482.3

Chil3

NM_009892.3

GAPDH

NM_017008

Primer (F: 5’-3’; R: 3’-5’)
F: CCCTTCAATGGTTGGTACATGG
R: ACATTGATCTCCGTGACAGCC
F: AAATGGCCTCCCTCTCATCAG
R: GTCACTCGAATTTTGAGAAGATGATC
F: ACAAGACAGGGCTCCTTTCAG
R: GGCTTATGGTTACCCTCCCG
F:AGAAGGGAGTTTCAAACCTGGT
R: GTCTTGCTCATGTGTGTAAGTGA
F: TCACCACCATGGAGAAGGC
R: GCTAAGCAGTTGGTGGTGCA

Size (bp)
158
73
148
109
169

Microglial cell cultures: Primary retinal microglia were isolated from mouse pups of both sexes P12P20 using standard methods

258,347

. Primary brain microglia were also isolated
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. In both cases,

mixed cell cultures were grown in media consisting of High Glucose DMEM (HG-DMEM; Invitrogen)
with 10% Fetal Bovine Serum (FBS; Sigma-Aldrich), 1% Penicillin/Streptomycin (Pen/Strep;
Gibco), 1% GlutaMAX (Gibco), and 1x MEM nonessential amino acids (Sigma-Aldrich). Upon
confluence, microglia were “shaken off” manually and plated in dishes coated with 0.1% Poly-LLysine (PLL; Peptides International, 0.01%) and Collagen IV (Corning, 4 µg/ml) in HG-DMEM with
5% FBS, plus 10% of media previously exposed to the mixed cell culture for 5-7 days. Media was
changed to DMEM with 5% FBS, 1% Pen/Strep, 1% GlutaMAX, and 1x MEM nonessential amino
acids 24 hours prior to experimentation.
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Time-lapse of morphological alterations: Retinal mouse microglia were plated as above and
incubated in Mg2+-free isotonic solution with 10 µM A839977 (Tocris) or DMSO as solvent control.
Phase contrast images were taken every 12s or 15s using a Keyence BZ-X700 Series All-in-One
Fluorescence Microscope (Keyence Corporation). BzATP (Sigma-Aldrich) was added in the
presence of A839977 or vehicle. Representative video was derived using “Focus tracking” function,
where time-lapse video is comprised of best-focused images derived from a panel of 7 images
spaced 0.7 µm apart at each time point. FIJI

362

was used to modify intensity, with parallel

processing for all time-lapsed sequences.
Immunocytochemistry: Isolated retinal microglial cells were mounted on 12mm glass coverslips
coated with PLL and collagen as above. Cells were fixed in 4% paraformaldehyde for 10 min at
37°C, washed in PBS with 1% Tween 20 (Bio-Rad), permeabilized with 0.1% Triton-X 100 for 15
min (Sigma-Aldrich) then blocked with 20% Superblock (Thermo Fisher) plus 10% goat or donkey
serum. Primary and Secondary antibodies used are listed in Supplementary Table 1. After
incubation in Hoechst (Cell Signaling, 1 µg/ml) for 10 min, coverslips were washed and mounted
using SlowFade Gold (Thermo Fisher). Imaging was performed using a Nikon Eclipse microscope
(Nikon) with NIS Elements Imaging software (Nikon v. 4.60). ImageJ was used in parallel
processing to modify intensity, and merge pseudocolored images. Retinal cryosections were
blocked with 1% Triton X-100, 0.5% Bovine Serum Albumin (BSA, Sigma-Aldrich), 0.9% Sodium
Chloride (Thermo Fisher), and 5% donkey serum (DKS; Jackson ImmunoResearch) in 1%
Phosphate-Buffered Saline (PBS-T-BSA), quenched using 0.3%, H2O2, then incubated with
primary antibody overnight at 4°C, rinsed, then blocked in PBS-T-BSA. Secondary antibody
incubated for 2 hrs followed by application of 4′,6-diamidino-2-phenylindole (DAPI; 1:2000).
Sections were mounted using Fluoromount-G (Southern Biotech). Images were acquired of from
retinal cryosections, using a Nikon Eclipse microscope (Nikon, USA) and NIS Elements Imaging
software (Nikon v. 4.60). All cells of the RGC and IPL layers were utilized for soma Iba1-intensity
measurements.
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Ca+2 imaging: Microglia were plated on 25 mm coverslips coated with PLL (0.01%) and Collagen
IV (4 µg/ml) and loaded with 10µM Fura-2 AM (Thermo Fisher) with 0.02% Pluronic F-127 (Thermo
Fisher) for 45 min at 37°C. Cells were washed, mounted in a perfusion chamber, and perfused with
isotonic solution without Mg2+. Ratiometric measurements were performed using a 40x objective
on a Nikon Diaphot microscope (Nikon) by alternating excitation between 340nm and 380nm
wavelengths and quantifying emission ≥512 nm with a charge-coupled device camera (All Photon
Technologies International) as described

131

. Data were expressed as the ratio of light excited at

340nm to 380nm, F340/380, due to complexity of calibration. Statistical comparisons were made by
averaging the peak value ± two measurements for all BzATP conditions and the average of the
final five measurements for the baseline conditions, including isotonic and A839966 in isotonic
solution.
Microglia migration: Mouse retinal microglia were grown to 80% confluence, detached,
resuspended in media outlined above to a concentration of 50,000 cells in 390 µl. After incubation
in inhibitors or vehicle for 1 hr, Hoechst (1 µg/ml) was added to cells for 10 minutes. The cell
suspension was added to the top wells of a chemotaxis chamber (Neuro Probe) separated from a
solution of 1 mM ATP (Sigma-Aldrich) in media by a 10 µm pore filter (Neuro Probe). Cells were
allowed to migrate for 3 hrs, after which unmigrated cells were removed from the top of the filter.
Filters were washed in Phosphate Buffered Saline, fixed in 4% PFA, then imaged using the
Fluoroskan fluorometer (Thermo Fisher) at 340ex/527em. Background fluorescence was
subtracted and data normalized to control. Fluorescence measurements were validated by
correlating fluorescence to labeled cell counts from images acquired of the underside of the pore
filter.
Vitreal ATP measurement: Given the difficulties in sampling the small extracellular spaces in the
retina without touching cells to trigger mechanosensitive ATP release or rupturing cells to trigger
cytoplasmic ATP release, levels in the posterior vitreous were determined. ATP concentration was
determined by enucleation after IOP returned to baseline and then fast-freezing eyes in dry ice.
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Eyes were later dissected over dry ice, and vitreal samples were collected by chipping away frozen
samples; this prevented intracellular ATP from the cut tissue edges from seeping into the vitreous
and contaminating the sample

250

. ATP levels were measured using the luciferin/luciferase assay

(Sigma-Aldrich) as described 21.
Intraocular pressure elevation. A transient controlled elevation of IOP (CEI) procedure was
produced in adult mice of both sexes using a modification of the approaches of Morrison
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and

Crowston 83 as previously described 6 to raise IOP to ~ 60 mmHg for 4 hours. Sustained elevation
of IOP was also induced using the microbead injection method as described 180.
Transient elevation of IOP: Mice were deeply anesthetized with 1.5% isoflurane after
receiving 2 mg/kg meloxicam. Proparacaine (0.5%) and tropicamide (0.5-1%) were administered
and one eye was cannulated with a 30- gauge needle attached to polyethylene tubing (PE 50;
Becton Dickinson) inserted into the anterior chamber, connected to a 20 ml syringe filled with sterile
PBS. IOP was increased to 57.0 ± 0.4 mmHg by elevating the reservoir to the appropriate height;
blood flow through the retina was maintained throughout to avoid acute ischemia, although some
reduction in blood flow is likely. After 4 hrs, IOP was returned to baseline, the needle removed, and
0.5% erythromycin was applied to the cornea. The contralateral eye without cannulation served as
a normotensive control. Retinal tissues were isolated 22-24 hrs after elevation of IOP.
Sustained elevation of IOP: Sustained elevation of IOP was induced using the microbead
injection method 352. Mice were anesthetized in 2.5% isoflurane, and 2 μL of magnetic microbeads
(COMPEL COOH-Modified 8-µm diameter; Bangs Laboratories) was injected into the anterior
chamber of the eye using a glass-pulled micropipette connected to a manual microsyringe pump
(World Precision Instruments) as described

180

. A neodymium magnet was used to draw the

magnetic beads into the iridocorneal angle, blocking aqueous humor outflow through the trabecular
meshwork and elevating IOP 352. Both eyes were injected with beads to eliminate the confounding
factor of contralateral eye effects on glial activation

345

. Separate mice injected with saline served

as controls. Minimum damage to ocular structures was observed. Ten IOP measurements per eye
using a TonoLab tonometer (Colonial Medical Supply) were averaged; a baseline measurement
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was taken before bead injection, then weekly measurements after bead injection. The IOP integral
(mm Hg-days exposure over baseline) was calculated to quantify cumulative IOP elevation

180

.

Fixed retinae were cryoprotected in 30% sucrose (Sigma Aldrich) and 0.02% sodium azide (Sigma
Aldrich) in 0.1M PBS and embedded in optimal cutting temperature medium. Sagittal sections at
10 to 15 μm using a Leica cryostat were obtained. Six to ten representative slides (three-four
sections/slide) were imaged using a Nikon Eclipse microscope (Nikon). Mean intensity of Iba1 in
microglia soma were analyzed using four sections per slide, and ten slides per retina using FIJI 362.
Data was derived from the central regions of the retina, consistent with above methods of intensity
measurements.
Data analysis: Statistical analysis was performed using GraphPad Prism software version 9.0.0
(Graphpad Software). Normality of data was tested using the Shapiro-Wilk test. Significant
differences between two unrelated groups were assessed by unpaired Student’s t-test; paired
Student’s t-tests employed when making comparisons between eyes of the same mouse. For
comparisons among three or more groups, one-way analysis of variance (ANOVA) with Dunnet’s
multiple comparisons (MC) test was used. For comparisons among groups with two variables, twoway ANOVA followed by Tukey’s multiple comparison’s test was applied. For quantification of
calcium imaging and sustained IOP measurements one-way ANOVA with repeated measures with
Sidak’s test for multiple comparisons was used. For Sholl analysis, two-way ANOVA with repeated
measures (RM) with Dunnet’s test for MC was used. Results returning p<0.05 were considered
significant. Data is represented as mean ± standard deviation.
2.4 Results
P2X7 receptor stimulation leads to morphologic and molecular activation of microglia in vivo.
The response of mouse retinal microglial cells to P2X7 receptor agonist BzATP was
investigated in vivo to determine if receptor stimulation was sufficient to evoke morphologic
changes. BzATP (250 μM) or saline control was injected intravitreally into eyes of C57Bl/6J mice,
and retinae removed after 24 hours; this dosage and time course were chosen based on previous
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trials 168,247. Treatment with BzATP led to elevated Iba1 staining and retracted microglial processes,
consistent with microglial activation (Fig. 2.1a, b) [6,7]. While some degree of increased staining
for Iba1 was found throughout the retinal layers (Fig. 2.1c, d), analysis was focused on the retinal
ganglion cell and inner plexiform layers as the response there was more consistent.
To quantify the extent of process retraction induced by P2X7 receptor stimulation, images
were traced to produce binary outputs, and Sholl analysis was performed (Fig. 2.1e, Supplemental
Figure S2.1a) 290. Retinal BzATP exposure led to a significant reduction in microglial process length
and complexity compared to saline controls (Fig. 2.1f). Peak intersection distance (Fig S2.1b) and
longest intersection distance (Fig. S2.1c) were both reduced upon exposure to BzATP.
Furthermore, the cumulative length of all branches was reduced by BzATP (Fig 2.1g), representing
approximately a 10% reduction in summed process length (Fig. S2.1d). Iba1 intensity was
measured in a defined area (5 μm) encircling the microglial soma in randomly selected microglia
from saline- or BzATP-injected eyes (Fig. 2.1h, i). Exposure to BzATP led to a significant elevation
of Iba1 immunostaining intensity when compared to control counterparts (Fig. 2.1j), reflecting a
combination of increased soma size and Iba1 expression. Analysis of individual images supported
microglial activation in retinae exposed to BzATP (Fig. S2.1e-i). Sholl analysis and soma staining
was supported by evaluation of Iba1 intensity and process retraction by masked observers, with
consistent signs of activation across all quadrants in retinae exposed to BzATP (Fig. 2.1k, S2.2ad).
qPCR was used to evaluate the molecular changes accompanying P2X7 receptor
stimulation. Genes associated with classical M1 activation, Nos2 and Tnfa, and genes associated
with the alternative M2 activation state, Arg1 and Chil3, were elevated in retinae 24 hours after in
vivo exposure to BzATP (Fig. 2.1l). Together, the morphological and molecular changes are
consistent with microglial activation after injection of agonist BzATP.
The response of microglial cells in isolated ex vivo retinal whole mounts to agonist BzATP
was examined to determine if resident microglia were sufficient for the observed increase in staining
and alterations in morphology following P2X7 receptor stimulation. Retinal whole mounts derived
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from heterogeneous mice with a fluorescent tag attached to microglia/macrophage receptor
Cx3CR1+/GFP were used to provide an additional method to track changes in microglial morphology.
Exposure to BzATP led to a considerable increase in fluorescence, with morphological changes
resembling those observed after BzATP injection in vivo (Fig. 2.2). The increased signal was most
noticeable around the optic nerve head (Fig. 2.2a, b), with prominent cell bodies apparent.
Exposure to BzATP also increased the signal throughout the central (Fig. 2.2c, d) and peripheral
retina, and across retinal layers (Fig. 2.2e, f). This ex vivo response in isolated retina suggests that
microglia normally resident within the retina are capable of responding to P2X7 receptor
stimulation, although it cannot rule out recruitment of additional monocytes following exposure in
vivo.
P2X7 receptor stimulation leads to morphologic and molecular activation of isolated microglial cells
Isolated microglia cells were examined to determine whether stimulation of the P2X7
receptor could induce effects on microglial cells directly. The relative staining for Iba1 and astrocyte
marker GFAP, and neural marker synaptophysin suggested preparations contained >95%
microglial cells (Fig. S2.3a, b). Similar analysis confirmed identity of brain microglia as shown in
more detail recently

60

. To support the microglial identity of the cells, the ability of

lipopolysaccharides (LPS) and interleukin-4 (IL-4) to induce expression of activation state markers
was determined using qPCR, as these two agonists are traditionally associated with classical and
alternative activation states, respectively 67,243. 4-hour stimulation of isolated retinal microglial cells
with LPS (10 ng/ml) increased expression of Nos2 and Tnf, while stimulation with IL-4 (10 ng/ml)
increased expression of markers for the alternative activation state such as Chil3 and Arg1 (Fig.
S3c). These responses resemble those recently found for isolated brain microglia
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and suggest

cells cultured under these conditions responded as predicted for microglial cells.
Immunocytochemical staining indicated Iba1-positive isolated retinal microglial cells
expressed the P2X7 receptor (Fig. 2.3a). Functional expression of the P2X7 receptor was assessed
by examining levels of cytoplasmic Ca2+ with the ratiometric indicator Fura-2. A one-minute addition
of BzATP raised cytoplasmic Ca2+ in the microglial cells (Fig. 2.3b, c); the response was rapid, with
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most cells showing a response within 20 sec. The response was also reversible upon wash-out of
BzATP, and repeatable upon reapplication; these characteristics are consistent with an ionotropic
channel with little inactivation like the P2X7 receptor as observed previously 142,367, and resembled
the response reported recently in isolated brain microglia
A839977

164

60

. The P2X7 receptor-specific inhibitor

significantly reduced the Ca2+ rise triggered by BzATP, with the robust response to

BzATP after removal of the A839977 confirming this decrease (Fig 2.3b, c). These responses
support the presence of functional P2X7 receptors on these isolated cells, while the responses to
IL-4 and LPS (Fig. S2.3c) supports their characterization as microglial cells.
The effect of BzATP on morphology of isolated microglia was examined to determine
whether changes observed in vivo could be replicated in the absence of other cell types. BzATP
triggered a retraction of microglial processes and a rounding of the cell body in greater than 75%
of observed cells (Fig. 2.4a). This response was rapid, starting less than 7 minutes after BzATP
application; an additional movie files show this in more detail (Fig. S2.4). The effect of BzATP on
microglial morphology was greatly reduced in the presence of inhibitor A839977, supporting action
of BzATP at the P2X7 receptor. This suggests that stimulation of the P2X7 receptor acting directly
on microglial cells was sufficient to trigger the rapid morphological changes seen in vivo.
Stimulation of the P2X7 receptor on isolated microglial cells also induced changes in gene
expression with parallels to those observed in vivo after P2X7 receptor stimulation. Specifically, the
endogenous agonist ATP (Fig. 2.4b), and P2X7 receptor agonist BzATP (Fig. 2.4c) both increased
expression of Nos2 and Arg1.
To determine if the effects of P2X7 receptor stimulation on microglial process retraction
extended to migration, chemoattraction of isolated retinal microglial cells to ATP was evaluated
using a 2-part Boyden Chamber. Imaging of the filter with bound microglia confirmed elevated
migration of retinal microglia towards an ATP concentration gradient (Fig. 2.4d). Measurements
indicated that the number of Hoechst-stained microglial cells closely reflected total Hoechst
fluorescence (Fig. 2.4e), with migration levels optimal 3 hours after the addition of cells to the
chamber. Microglial migration towards 1 mM ATP was inhibited by inclusion of P2Y12 receptor
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inhibitor AR-C 69931 with the ATP, but not inclusion of P2X7 receptor inhibitor A839977 with the
ATP (Fig. 2.4f), suggesting the effects of P2X7 receptor stimulation are focused on retraction of
ramifications and not the actual migration of retinal microglia.
Role of ATP and the P2X7 receptor in pressure-dependent microglial activation
Given that increased IOP is associated with both ATP release and microglial activation,
experiments investigated the role of the P2X7 receptor in the morphological and molecular changes
induced by IOP elevation. The effect of moderate transient IOP elevation on microglia cells was
examined by increasing IOP to 57 mmHg for 4 hours, with retinal whole mounts fixed 24 hours later
and stained for Iba1; previous studies indicated robust inflammatory responses at this point 6. Iba1
staining revealed a noticeable change in microglial morphology in eyes exposed to elevated IOP,
with larger cell bodies and shorter processes in retinal tissue exposed to elevated IOP as compared
to control (Fig. 2.5a). As mechanosensitive release of ATP is an early and sustained event found
after pressure elevation in bovine, mouse, rat and primate eyes

6,250,340

, ATP concentration was

determined as soon as pressure returned to baseline in the transient model. ATP levels sampled
in the vitreal humor near the inner limiting membrane were significantly elevated in eyes subjected
to increased IOP as compared to normotensive controls (Fig. 2.5b). Given the presence of elevated
ATP, the response to IOP elevation was examined in retinae from P2X7-/- mice. Microglia cells from
P2X7-/- mice showed a smaller change in morphology after transient IOP elevation (Fig. 2.5c).
Histological quantification confirmed a clear increase in the morphological signs of activation in
microglial cells from retinae of C57Bl/6J retinae following IOP elevation, and a reduced sign of
activation in retina from P2X7-/- mice (Fig. 2.5d).
The pattern of gene change following transient IOP elevation was similar to that found after
BzATP injection, with elevation of classical activation markers Nos2 and Tnfa, and genes
associated with the alternative activation state, Arg1 and Chil3 (Fig. 2.5e). The expression of genes
Tnfa and Arg1 increased in retina of P2X7-/- mice after exposure to elevated IOP, but the rise was
smaller and there was no significant change in Nos2 or Chil3 expression (Fig. 2.5f). Overall, the
change in expression of genes following IOP elevation was reduced in retina from P2X7-/- mice as
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compared to C57Bl/6J mice (Fig. 2.5g). Altogether, both morphological and molecular changes
following transient IOP elevation are consistent with a contribution from the P2X7 receptor.
As glaucoma is primarily a chronic disorder, responses were examined in retinae from
C57Bl/6J mice subjected to sustained elevation of IOP via magnetic bead blockage of aqueous
humor outflow (Fig. 2.6a,b). Similar morphological differences were observed in Iba1 stained cells
in the sections from central retinal regions of mice with bead injection, including retraction of
processes, cell soma swelling, and increased expression of Iba1 when compared to saline-treated
retinae (Fig. 2.6c). Quantification of Iba1 intensity in the soma area showed significant elevation
with sustained IOP elevation (Fig. 2.6d).
Retinal ganglion cell loss, microglial activation and the P2X7 receptor
The relationship between microglial activation, the P2X7 receptor and retinal ganglion cell
loss was examined to better understand the consequences of microglial activation to ganglion cell
health. Retinal whole mounts used above were co-stained for the ganglion cell transcription factor
Brn3a and the number of cells present in each of the 24 regions (see Fig. S2.1i) were counted. In
C57Bl/6J mice, IOP elevation led to a modest reduction in Brn3a-positive cells as compared to
normotensive eyes (Fig. 2.7a), although little change was seen in P2X7-/- mice (Fig. 2.7b).
Quantification confirmed a significant decline in the number of Brn3a-positive cells with IOP
elevation in C57Bl/6J mice, but not P2X7-/- mice (Fig. 2.7c). Close overlap between microglial and
retinal ganglion cells occurs throughout the retina (Fig. 2.7d), although quantification indicated the
ratio of microglia to RGCs differed in peripheral regions as compared to central and middle areas
(Fig. S2.5a,b), supporting the focus on these regions. Analysis of activation from individual images
across retinal regions supports these findings for microglial and retinal ganglion cell quantification
(Fig. S2.5b, c).
The microglial activation score was compared to ganglion cell number in all images in the
central and middle areas for C57Bl/6J mice (Fig. 2.7e), and P2X7-/- mice (Fig. 2.7f). Images with
fewer ganglion cells tended to show greater microglial activation; this relationship was greater for
C75Bl/6J mice (slope -27.0) than for P2X7-/- mice (slope -10.7). The correlation between microglial
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activation score and ganglion cell number was closer for C75Bl/6J mice with a Pearson’s r of 0.442,
vs 0.227 for P2X7-/- mice, although considerable variability across the eyes and between mice of
both strains limited the strength of the overall correlation.
2.5 Discussion
The data presented in this manuscript illustrate several complex consequences of P2X7
receptor activation in microglial cells. Detailed morphological analysis indicated that administration
of P2X7 receptor agonist BzATP to murine retina in vivo reduced branch length, and increased
soma size and Iba1 expression in microglial cells, emblematic of microglia activation. Furthermore,
retinal exposure to BzATP led to gene expression upregulation of Nos2, Tnfa, Arg1, and Chil3,
associated with microglial activation into a mixed classical (M1)/alternative (M2) state. Ex vivo
retinal explants demonstrated comparable morphological changes following exposure to BzATP.
Isolated retinal microglial cells displayed parallel molecular changes after exposure to ATP or
BzATP in vitro, with upregulation of classical activation marker Nos2 and alternative activation
marker Arg1. Transient elevation of IOP led to similar morphological changes, with larger cell
bodies and shorter processes, and increased expression of Nos2, Tnfa, Arg1, and Chil3. However,
both morphological and molecular changes were reduced in retinae from P2X7-/- mice. The
similarities in the morphological and molecular changes induced by BzATP and elevated IOP,
combined with the reduced responses in P2X7-/- mice to IOP elevation, implicate the P2X7 receptor
in some of the early inflammatory responses to increased pressure in the retina.
Several observations strengthen the findings of this study. 1) The convergence of
morphological evidence from in vitro and in vivo experiments supports the validity of conclusions,
with rapid retraction of microglial extensions within moments of BzATP application to isolated cells
complementing the detailed Sholl analysis in vivo; 2) Convergent molecular data from in vitro and
in vivo experiments imply P2X7 receptor stimulation upregulates markers traditionally associated
with both M1 and M2 activation states; 3) Parallel morphological effects of BzATP on retinal
explants imply resident retinal microglial cells were sufficient to produce this response without
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recruitment of external cells; 4) While BzATP can act at other purinergic receptors, use of P2X7-/mice, combined with antagonist A839977 (IC50 150 nm, 164) and immunohistochemical identification
strongly implicates the P2X7 receptor; 5) Boyden chamber studies suggest the P2X7 receptor
effect is focused on retraction of microglial ramifications and not on chemoattractant migration; 6)
Use of models for both transient and sustained elevation of IOP, combined with live-cell imaging,
strengthen understanding of the time course of the response to P2X7 receptor stimulation. Overall,
the data considerably extend our understanding of the P2X7 receptor, microglial activation and
increased pressure.
P2X7 receptor and microglial activation states
The data above support the theory that the molecular response to transient P2X7
stimulation represents a mixed M1/M2 microglial cell state. A 4-hour stimulation of the P2X7
receptor in cultured microglia with 1 mM ATP or 200 μM BzATP upregulated classical activation
gene marker Nos2 and alternative activation gene marker Arg1 (Fig. 2.4b,c), paralleling
upregulation of classical activation markers Nos2 and Tnfa and alternative activation markers Arg1
and Chil3 with in vivo administration of BzATP, or elevation of IOP (Fig. 2.1l; Fig.2.5e). P2X7
receptor stimulation had been shown to lead to upregulation of classical activation markers in in a
variety of inflammatory cell types

3,52,378

, with a study on the SOD-G93A model of Amyotrophic

Lateral Sclerosis suggesting upregulation of alternative activation markers 103. Given the emerging
role of the P2X7 receptor in modulating phagocytosis, autophagy and lysosomal clearance by
microglial cells
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, this mixed activation may have important implications for the health of aging

tissues. Previous studies utilizing acute elevation of IOP in rats have focused on neurotoxic
cytokine release from microglia

392

. However, directing microglia away from neuroinflammatory

states is a putative therapeutic for conditions like brain trauma that are accompanied with transient
ATP elevation

4,169,208

. A full understanding of putative anti-inflammatory therapies for glaucoma

and their effects on microglia, such as P2X7 receptor inhibition
antibiotics

22,40

, or downstream effectors

122

110,346

, carbon monoxide

46,432

,

will help elucidate the role classical and alternative

activation pathways play in retinal degeneration.
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Microglial activation as an early event in retinal degeneration.
The findings above add relevant details to a growing body of evidence implicating microglial
activation in various retinal degenerations including glaucoma. Activated microglia and associated
inflammatory markers TNF-α and NOS-2 have been detected at the optic nerve head in human
glaucomatous eyes 302,441. Morphological changes to microglial cells were detected in 3 month old
DBA/2J mice, prior to detection of neural damage
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, and documented 3 days after induction of

ocular hypertension in rats 94,298. Purinergic involvement in the microglial response was suggested
by the ability of purinergic receptor blocker OxATP to inhibit the rise in CD68 expression in rat retina
following transient elevation of IOP to 90 mm Hg
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. Qualitative analysis also suggestsed

antagonist Brilliant Blue G reduced staining of Iba1 following injection of hypertonic saline into rat
episcleral veins 94. The current study indicates the microglial response occurs early, with activation
found 24 hours after BzATP administration (Fig. 2.1), 24 hrs after a 4 hour elevation of IOP (Fig.
2.4), and with retraction occurring within minutes of receptor stimulation in vitro (Fig S2.4). Within
this context, the inability of P2X7 antagonist A839977 to significantly prevent microglial migration
(Fig. 2.4f) distinguishes process retraction from cell migration; whether the P2X7 receptor interacts
with THIK-1 channel recently implicated in microglial surveillance remains to be tested using
sufficiently high agonist levels 260.
The relationship between microglial activation and retinal ganglion cell loss is complex.
Detailed analysis of microglial activation and surviving ganglion cell number indicates an inverse
correlation following IOP elevation which was reduced in P2X7-/- mice (Fig. 2.7). While it is tempting
to assume this implicates microglial activation in ganglion cell death via the P2X7 receptor, several
observations urge caution. For example, the variation amongst the 24 images analyzed per retina
and between mice was considerable, weakening the correlation. In addition, stimulation of the P2X7
receptor can directly kill retinal ganglion cells

168

, while ganglion cell death can itself lead to

microglia activation 397. Activation of A1 astrocytes has been implicated as a key step in pressurerelated ganglion cell death

231,383

, and the geometric relationship between astrocytes, microglial

cells, ganglion cell soma and ganglion cell axons is complex, especially as the axons are thought
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to be a primary target in glaucomatous pathology

387,403

. P2X7 receptor inhibition has been

implicated as a therapeutic strategy for several retinal diseases including Age-related Macular
Degeneration

110,309

, Diabetic Retinopathy

71,116,325,326

, and glaucoma

247,281,323,346,392

. While topical

administration of a P2X7 receptor antagonist preserved general RGC function in the DBA2/J model
346

, recent work suggests the P2X7 receptor also has beneficial effects on retinal ganglion cells

after moderate IOP elevation

421

, and can trigger the release of neuroprotective cytokine IL-3

233

.

These complex responses may also reflect the mixed microglial activation state response identified
in the present study. The precise relationship between microglial activation, ganglion cell death and
the P2X7 receptor is likely context dependent and awaits future clarification.
In summary, our results support a model whereby P2X7 receptor stimulation alone is
sufficient to cause microglial activation, and that this activation occurs rapidly after receptor
stimulation or following ATP release with elevation of intraocular pressure. Furthermore, although
the P2X7 receptor is traditionally associated with its proinflammatory role3, P2X7 receptor
stimulation here led to a mixed activation state in microglial cells, suggesting the response is
complex. Microglia activation was increased with elevated IOP, reduced in P2X7-/- mice and was
loosely associated with loss of retinal ganglion cells following increased IOP. The impact of the
mixed M1/M2 activation state on the response to P2X7 receptor stimulation, and the corresponding
influence on both inflammation and phagocytosis/clearance needs to be determined

60

. As P2X7

receptor modulation is being targeted for retinal disorders 110, the quantitative approaches used in
this study can add to a deeper understanding of P2X7 receptor signaling and any putative beneficial
effects.
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2.6 Figures

Figure 2.1. Retinal P2X7 receptor stimulation leads to activated microglia morphology and
gene expression. Representative images from retinae fixed 24 hrs after intravitreal injection
with saline (a) or 250 μM BzATP (b) indicated BzATP exposure led to greater Iba1 expression
and altered morphology. c, d Z-projections of retina whole mounts demonstrate increased Iba1
staining in the IPL and RGC layers of the retina with BzATP exposure. e Representation of
tracing and conversion of Iba1 staining to a binary image for Sholl analysis. f. Sholl analysis
indicated reduced branching complexity of microglia exposed to BzATP (2-way RM ANOVA with

40

Sidak’s MC Test; n=3 mice; Significance represents Interaction value of ANOVA). g Summed
branch length is reduced in microglia exposed to BzATP as compared to Saline (paired Student’s
t-test; n=3 mice). Cell soma size and Iba1 intensity are determined in circled area (yellow ring, 5
µm diameter) of microglia cell body from retinae exposed to (h) saline vs. (i) BzATP. j
Quantification of Iba1 intensity in selected area (paired Student’s t-test; n=3 mice). k Observer
scoring of images taken from saline- or BzATP-exposed retinae showing Iba1-positive microglia
are activated with BzATP exposure (paired Student’s t-test; n=3 mice; normalized to average
saline value). l Expression of both classical M1- activation genes Nos2, Tnfa, and alternative M2
activation genes Arg1, Chil3 are elevated in retinae exposed to BzATP (paired Student’s t-test;
n=7 mice). Statistical significance shown at *p<0.05, **p<0.01, ****p<0.0001. Scale bars
represent 40 μm (a), 15 μm (d), 25 μm (e, h).
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Figure 2.2. Ex vivo retinal whole mount P2X7 receptor stimulation activates microglia. a,
b Retinal whole mounts isolated from Cx3CR1+/GFP mice revealed increased fluorescence at the
optic nerve head compared to control media (a) after exposure to 200 µM BzATP for 2 hours in
a petri dish (b). This elevation in fluorescence was also seen in the Middle Nasal areas when
comparing control media (c) to BzATP exposure (d). e, f Z-projection of Middle-Nasal retinae
exposed to control media or BzATP. Bar = 50 μm.
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Figure 2.3. Isolated microglial cells express P2X7 receptor on protein and functional
levels. a Immunostaining of P2X7 receptor (green) in primary retinal microglial cells stained
positive for Iba1 (red). Bar = 10µm. b Representative trace from a retinal microglia cell loaded
with Fura-2 showing elevation in cytoplasmic Ca2+ in response to BzATP (100 μM, Mg2+ free
solution). Data displayed as the ratio of light excited at 340/380 nm, emitted > 520 nm (referred
to as “F(340/380)”). The response to BzATP was transiently reduced by 1μM P2X7 antagonist
A839977 (A83). c Quantification of the response in multiple cells (RM 1-way ANOVA with Sidak’s
MC Test; n=12 cells from 3 culture preparations).
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Figure 2.4. Isolated retinal microglia respond to P2X7 receptor stimulation with rapid
retraction, gene activation but not migration. a Images of isolated retinal microglial cells taken
before (left) and ~ 8 min after (right) application of isotonic solution (Control), 250 μM BzATP
(BzATP), or 250 μM BzATP (BzATP) ± 10 μM A839977 (A83) suggests P2X7 receptor leads to
process retraction in vitro. Similar responses were found in >7 experiments. Bar=10µm, real time
in min on image; solution added at minute 3:00; see Fig. S4 for video. Elevated expression of
Nos2 and Arg1 was detected in cultured retinal microglial cells following 4 hr exposure to 1 mM
ATP (b, n=9 wells from 3 culture preparations) or 200 μM BzATP (c, n=3 wells from 1 culture
preparation; unpaired Student’s t-test). d Representative images of isolated retinal microglial
cells with Hoechst-stained nuclei after passing through a Boyden chamber, indicated that
microglia migrate towards a 1 mM ATP gradient. Bar=50 μm. e Correlation between number of
Hoechst-stained nuclei in brain microglia per well and fluorescence at 340ex/527em (Pearson’s
correlation r = 0.9396 with p = 0.0001; n=17 wells from 1 culture preparation). f Migration of
retinal microglia towards 1 mM ATP was inhibited by exposure to 10 μM P2Y12 inhibitor AR-C
69931 (ARC) in the presence of ATP but not 1 μM A839977 (A83) in the presence of ATP. (1way ANOVA with Sidak’s MC Test; n=17 Ctrl, 20 ATP, 20 ARC, 19 A83 wells from 4 culture
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preparations). Statistical significance shown as **p<0.01, ***p<0.001, ****p<0.0001, ns=not
significant.
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Figure 2.5. Elevation of IOP releases ATP and activates microglia through P2X7 receptor
involvement. a Representative image of staining for Iba1 in a retinal whole mount from an
unpressurized C57Bl/6J mouse eye (Ctrl, left) and from an analogous region 20 hrs after
elevation of IOP to 57 mmHg for 4 hrs (right). Retinal microglia subject to IOP elevation showed
increased soma size, increased staining for Iba1, and shorter, thicker projections. Bar=20µm. b
Increase in ATP concentration of posterior vitreous humor after elevation of IOP (paired
Student’s t-test; retinal pairs from 3 mice). c Iba1 staining from a P2X7-/- mouse indicates
reduced morphological activation after elevation of IOP (right) when compared to unpressurized
retina (left). d Quantification of morphological activation of microglia across central and middle
regions suggests IOP elevation triggered greater morphological activation in C57Bl/6J than
P2X7-/- retinae (2-way ANOVA with Tukey’s MC test; dots are n=10 retinae from 5 mice per
C57Bl/6J, P2X7-/- strain; data normalized to unpressurized score for each strain). qPCR showing
increased expression of Nos2, Tnfa, Arg1, and Chil3 in the retina after elevation of IOP in
C57Bl/6J (e) mice. Dots represent change in expression from a single mouse, with expression
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normalized to the average DDCT value of unpressurized contralateral eyes (paired Student’s ttests; Nos2: n= 5 mice, Tnfa, Arg1, Chil3: n= 6 mice). f A small but significant increase was
observed in retinal gene expression of Arg1, and Tnfa, but not Nos2 or Chil3 after IOP elevation
in P2X7-/- mice (Paired Student’s t-tests; Nos2 n=6 retinae from 3 mice, Tnfa, Arg1, Chil3, n=12
retinae from 6 mice). g Relative change in retinal expression of key genes after elevation of IOP
in C57Bl/6J mice compared to P2X7-/- mice. Values represent mean DDCT levels for each gene
compared to unpressurized control retinae (unpaired Student’s t-test; n=5 genes). Statistical
significance shown as *p<0.05, **p<0.01 ***p<0.001, ****p<0.0001, ns=not significant.
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Figure 6
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Figure 2.6. Microglial activation in bead model of sustained ocular hypertension. a Weekly
IOP measurements from mice injected with magnetic beads (red) or saline control (black; 1-way
RM ANOVA with Sidak’s MC test). b The IOP integral (right) expressed as summed mmHg days
exposure over baseline IOP, for bead and saline-injected eyes (unpaired Student’s t-test). c
Representative staining for Iba1 in cryosections 7 weeks after injection with saline (top) or beads
(bottom), suggesting sustained elevation of IOP also induces changes in the microglial
phenotype emblematic of activation. Bar=50 μm. d Quantification of a 5 μm area surrounding the
soma indicates significant elevation of Iba1 intensity per cell in bead-injected mice (unpaired
Student’s t-test). All data from Ctrl: n=4 retinae from 3 mice, Bead: n=3 retinae from 3 mice.
Statistical significance shown as *p<0.05.
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Figure 2.7. Ganglion cell death and microglial activation. a Representative images show that
staining for RGC marker Brn3a is decreased in retinae 1 day after a 4 hr IOP elevation (right)
compared to unpressurized C57Bl/6J mice (Ctrl; left). b A decrease in Brn3a staining was not
observed in retinae from P2X7-\- mice after IOP elevation as compared to unpressurized control
eyes. c There was a significant decline in Brn3a-labeled RGCs in retinae exposed to elevated
IOP compared to normotensive controls from C57Bl/6J eyes, but not P2X7-/- mice (*p=0.0017,
paired t-test with line connecting normotensive and elevated IOP from same mouse, n=5 mice,
mean of ~ 24 images per eye). d Retinal whole mount from a C57Bl/6J mouse showing the
spatial relationship between RGCs stained with Brn3a (red) and microglia stained with Iba1
(green); images show staining across the central region with the optic nerve head (left), the
middle region (center), and peripheral areas (right), of the retina. Relationship between RGC
number and microglial activation score for C57Bl/6J (e) and P2X7-/- mice (f) under normotensive
(grey) and elevated IOP (red) conditions. Small symbols from individual images (up to 24 per
eye) while larger squares represent mean values per eye (n=5 per condition). Lines are linear
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regression fit to image data (C57Bl/6J: F=37.70, (1,155) p<0.0001, R2=0.196; P2X7-/- F=8.22,
(1,152), p=0.0047, R2=0.05).
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Supplementary Figure S2.1. Details of Sholl and other image analysis. a Representations
of i- Iba1 staining; ii- image tracing, iii - concentric rings placed every 5µm for analysis of crossing
and length; and iv - conversion to a binary image. Bar = 25 µm. b, c Tracings were analyzed for
distance from soma at which peak number of intersections with concentric rings (b) and farthest
intersection with concentric ring (c) occurred (paired Student’s t-test; n = 6 retinae of 3 mice). d
Total summed branch length averaged per mouse was reduced by approximately 10% (paired
Student’s t-test; n = 6 retinae of 3 mice; Normalized to mean saline injected= 1.0000, mean 250
µM BzATP = 0.8914). e Sholl analysis performed with individual cells (2-way Repeated
Measures ANOVA with Sidak’s Multiple Comparison’s Test; n = 41 Saline, 46 BzATP) cells from
6 retinae of 3 mice; significance represents Multiple Comparison’s, data measured every 5 μm).
f, g Absolute (f) and normalized (g, to avg saline) of Sholl data from individual images confirms
reduction in branch length of microglia exposed to BzATP (unpaired Student’s t-test; n = 41
Saline, 46 BzATP cells from 6 retinae of 3 mice; Normalized mean saline = 0.9941, mean BzATP
= 0.8930). h Quantification of Iba1 intensity in 5µm ring around soma of individual cells from 6
retinae from 3 mice (unpaired Student’s t-test; n = 60 saline, 55 BzATP cells from 6 retinae of 3
mice). i. Schematic diagram indicating approximate placement of images analyzed for microglia
and RGCs. *p<0.05, **p<0.01, ****p<0.0001.
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Supplementary Figure 2.
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Supplementary Figure S2.2. Validation of observer scoring. a Representative images
derived from Iba1-immunostained retinal whole mounts indicating a score of 1, 2, or 3.
Bar=50µm. b A significant correlation between observer scoring and microglial Iba1-soma
intensity was found. Observer scoring was normalized to the mean of 3 saline injected mice,
while soma intensity was quantified in a 5µm diameter ring as described in Figure 1. Each dot
represents the mean value among masked, trained observers (Pearson’s correlation r = 0.6882
with p = 0.0006; n = 21 images, 6 retinae from 3 mice). c Scoring of microglial activation shows
homogeneity between trained observers. d Observer scoring of images taken from saline- or
BzATP-exposed retinae analyzed by image (unpaired Student’s t-test; n = 12 saline, 9 BzATP
images, from 6 retinae of 3 mice). **p<0.01. Bar = 50 μm.
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Supplementary Figure S2.3. Confirmation of cellular identity of isolated microglial cells.
a Immunocytochemistry indicating absence of glial marker GFAP (top) or neuronal marker
synaptophysin (Synapt, bottom) in primary cultures of retinal microglial cells. Bar=20µm. b
Isolated brain microglial cells stained for Iba1 but not GFAP. Bar=20µm. c qPCR results from
cultured retinal microglial cells exposed for 4 hrs to DMSO (Ctrl), 10 ng/ml LPS (LPS), or 10
ng/ml IL-4 (IL4); changes in relative expression of mRNA for Nos2, Tnfa, Arg1, and Chil3 were
consistent with microglial cells polarization. (n=6-9 samples from 2-3 biological replicates).

53

a

b

Supplementary Figure S2.4. Videos demonstrating microglial retraction with exposure to
BzATP. Videos demonstrating microglial retraction with exposure to BzATP. 15 minute videos
were recorded at 15 frames per second, with all solutions added at t = 3 min. a Addition of fresh
control solution led to few morphological changes. b Addition of 250 μM BzATP resulted in rapid
retraction of microglial extensions and rounding of cells.
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c

Supplementary Figure S2.4 (continued). c In the presence of 10 μM A839977 (and following
30 min preexposure to 10 μM A839977) ,250 μM BzATP induced little retraction. All solutions
Mg2+-free to prevent block of the P2X7 receptor.
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Supplementary Figure S2.5. Microglia and cell counts in the retina. a RGCs (left) and
microglia (right) cell numbers were counted per image and averaged within superior inferior,
nasal, or temporal regions. There was a significant difference in distribution of RGCs in
peripheral retinal areas (RM 1-way ANOVA with Sidak’s MC test; n=12 regions from 3 mice). b
Quantification of morphological activation from individual images of microglia across central and
middle regions suggests greater activation in C57Bl/6J retinae than in P2X7-/- retinae (2-way
ANOVA with Tukey’s MC test; n=52 regions from 10 retinae derived from 5 mice per C57Bl/6J,
P2X7-/- strain; data normalized to unstimulated score for each strain). c RGC numbers counted
in central and middle fields under normotensive (Ctrl) and increased IOP in mice from both
genotypes. Statistical significance shown as ** p<0.01, ***p<0.001, ****p<0.0001, ns=not
significant.
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CHAPTER 3: STIMULATION OF THE P2X7 RECEPTOR CONTRIBUTES TO GENERATION
OF NEUROTOXIC REACTIVE ASTROCYTES

3.1 Abstract
Neuronal death is associated with polarization of astrocytes into the A1 neuroinflammatory
state. While this polarization can be initiated by release of C1q, TNF-α and IL-1α from microglial
cells, the upstream effectors stimulating their release are unclear. This preliminary study
investigates the role of P2X7 receptor (P2X7R) stimulation in the increase in these inflammatory
signals and the effects on transcription of astrocyte inflammatory genes. 250 µM of P2X7R agonist
BzATP. qPCR was performed on retinae 24 hrs after intravireal injection of 250 µM P2X7 agonist
BzATP. Additionally elevation of intraocular pressure (IOP) was applied to C57Bl/6J or P2X7-/retinae for 4 hrs, with subsequent isolation of retinae 22 hrs later for qPCR analysis. Intravitreal
injection of P2X7 receptor agonist BzATP increased expression of Tnfa, Il1a, and C1qa. Levels of
pan-reactive, A1-specific, and 2 A2-specifc genes were elevated, with activation was most
consistent with the A1 state. Preliminary data evaluating the effects of IOP on retinal gene
expression in C57Bl/6J mice indicated elevated expression of Tnfa and Il1a, A1-specific gene
Serping1, and upregulation of A2-specifc genes CD14, Ptx3, and Clcf1. Trending upregulation
(p<0.1) was observed of pan reactive astrocyte genes Gfap and Vim, and A1-specific genes C3
and H2T23. Elevation of IOP in P2X7-/- retinae resulted in no upregulation of microglia or astrocyte
inflammatory genes. Taken all together, this implicates P2X7R stimulation in promotion of microglia
inflammation, and astrocyte polarization into an A1 neurotoxic state. Surprisingly, preliminary data
suggests that P2X7R involvement in the elevation of IOP is less clear, with upregulation of A2
neuroprotective genes, and trending upregulation of A1 genes observed in C57Bl/6J retinae but
not P2X7-/- retinae. Caution should be merited before any encompassing conclusion can be made,
as further experimentation to support this data is necessary.
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3.2 Introduction
Mechanical strain is associated with the release of ATP in many tissues20,81,426, where it
mediates an inflammatory response through ionotropic P2X or metabotropic P2Y receptors51,234.
The P2X7 receptor (P2X7R) is a major inflammatory receptor of the Central Nervous System
(CNS)3. Stimulation of P2X7R with high concentrations of ATP lead to activation of the NLRP3
inflammasome and release of inflammatory cytokines3,129,359. Signaling mechanisms elucidated in
models of mechanical strain provide valuable insight into pathology of glaucoma, where
symptomatic elevated intraocular pressure contributes to optic nerve damage and blindness
through unknown mechanisms415,428.
Recent work has pointed to the loss of neural populations in models of mechanical strain
as mediated by neurotoxic astrocytes145,383. Reactive astrocytes have been detected in several
models of neurodegeneration145,231,383,442. Astrocytes respond to inflammatory effectors by adopting
A1 pro-inflammatory or A2-neuroprotective forms, as defined by transcriptional alterations444.
Neurotoxic astrocytes were induced by exposure to cytokines IL-1α, C1q, and TNF-α in vitro
leading to loss of neurons231. Deletion of Il1a, Tnfa, and C1qa protected neurons and reduced
neurotoxic astrocyte gene upregulation in mouse models of chronic elevation of IOP145,383.
However, upstream mediators that lead to release of these cytokines are unclear.
Microglia are implicated as primary effectors of release230,231. Microglia are the primary
innate immune effector cells of the retina, where they play roles in retinal homeostasis, cytokine
release, and phagocytosis of apoptotic cells374. Microglia activation into an inflammatory state is
contributes to neuron loss in the DBA/2J model of elevated IOP42 and in human glaucoma441.
Microglia are the major source of IL-1α412, C1q47,111,320, and TNF-α330. Moreover, microglia are the
major cell type to express P2X7R189. P2X7 receptor stimulation results in release of IL-1α129 and
TNF-α (REF). Taken together, these implicate microglial P2X7R as key mediators of neurotoxic
astrogliosis developed from elevated IOP.
Using in vivo administration P2X7R agonist BzATP and elevation of IOP in models where
the P2X7 receptor is deleted (P2X7-/-), we confirm the central role that the receptor has in triggering
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astrogliosis. We demonstrate that retinal injections of BzATP upregulate gene expression of Tnfa,
Il1a, and C1qa, as well as genes associated with A1-specific astrocytes. Additionally, elevation of
IOP in C57Bl/6J mice upregulated retinal expression of Tnfa and Il1a, with significant or trending
upregulation of both A1- and A2-specific astrocyte transcripts. Gene upregulation of Tnfa, Il1a, or
astrocyte inflammation was not observed in P2X7-/- that was subjected to elevated IOP. Thus, we
demonstrate that P2X7R stimulation mediates factors associated with astrocyte inflammation that
accompany IOP-induced mechanical strain.
3.3 Methods
Animals care and use
All procedures were performed in strict accordance with the National Research Council’s “Guide
for the Care and Use of Laboratory Animals”. All procedures were approved by the University of
Pennsylvania Institutional Animal Care and Use Committee (IACUC) in protocol #803584. All
animals were housed on a 12:12 light:dark cycle in temperature-controlled rooms with food and
water ad libitum. Mice (C57Bl/6J wild type and P2XR7-/- B6.129P2-P2rx7tm1Gab/J Pfizer were
obtained from Jackson Laboratories (Bar Harbor, ME).
Intravitreal Injections
Intravitreal injections were performed as previously described168. In brief, C57Bl/6J mice were
anesthetized with 1.5% isofluorane, and subsequently injected under a dissecting microscope
using a micropipette attached to a microsyringe (Drummond Scientific Co., Broomall, PA, USA).
1.5 μl was injected the vitreous cavity approximately 0.5 mm anterior to the limbus, into superior
nasal region of the sclera. Injections consisted of Sterile Balanced Saline solution as a control with
or without 250 μM Benzoylbenzoyl-ATP (BzATP, #B6396, Sigma Aldrich). Retinae were isolated
24 hrs later. The concentration and time course of isolation after administration was chosen based
upon previous trials6,247.
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Table 3.1: Primers used for qPCR
Gene name Genbank accession
Tnfa
NM_013693.3
Il1a

NM_010554.4

C1qa

NM_007572.2

Gfap

NM_001131020.1

Steap4

NM_054098.3

Vim

NM_011701.4

Lcn2

NM_008491.1

SerpinA3N

NM_009252.2

Aspg

NM_001081169.1

C3

NM_009778.3

Serping1

NM_009776.3

H2D1

NM_010380.3

H2T23

NM_010398.3

Amigo2

NM_178114.4

Fkbp5

NM_010220.4

Fbln5

NM_001361987.1

CD14

NM_009841.4

Ptx3

NM_008987.3

Clcf1

NM_019952.5

Emp1

NM_010128.4

Slc10a6

NM_029415.2

GAPDH

NM_017008

Primer (F: 5’-3’; R: 3’-5’)
F: AAATGGCCTCCCTCTCATCAG
R: GTCACTCGAATTTTGAGAAGATGATC
F: CAACGTCAAGCAACGGGAAG
R: AAGGTGCTGATCTGGGTTGG
F: GAAGGGCGTGAAAGGCAATC
R: CAAGCGTCATTGGGTTCTGC
F: CCTGCCAGCTCTCCCT
R: AAAGGTGTGGCTGAAATGCG
F: CCCGAATCGTGTCTTTCCTA
R: GGCCTGAGTAATGGTTGCAT
F: GATGGCCCTGGACATTGAGA
R: TTGAGTGGGTGTCAACCAGAG
F: CCAGTTCGCCATGGTATTTT
R: CACACTCACCACCCATTCAG
F: GCTGGCTGGTTTCAGCTCT
R: ATCCATTCCCAACGTGCCAT
F: GCTGCTGGCCATTTACACTG
R: GTGGGCCTGTGCATACTCTT
F: TTCCTTCACTATGGGACCAGC
R: CTCCAGCCGTAGGACATTGG
F: ACAGCCCCCTCTGAATTCTT
R: GGATGCTCTCCAAGTTGCTC
F: TCCGAGATTGTAAAGCGTGAAGA
R: ACAGGGCAGTGCAGGGATAG
F: GGACCGCGAATGACATAGC
R: GCACCTCAGGGTGACTTCAT
F: GAGGCGACCATAATGTCGTT
R: GCATCCAACAGTCCGATTCT
F: TATGCTTATGGCTCGGCTGG
R: CAGCCTTCCAGGTGGACTTT
F: CTTCAGATGCAAGCAACAA
R: AGGCAGTGTCAGAGGCCTTA
F: GGACTGATCTCAGCCCTCTG
R: GCTTCAGCCCAGTGAAAGAC
F: AACAAGCTCTGTTGCCCATT
R: TCCCAAATGGAACATTGGAT
F: CTTCAATCCTCCTCGACTGG
R: TACGTCGGAGTTCAGCTGTG
F: GAGACACTGGCCAGAAAAGC
R: TAAAAGGCAAGGGAATGCAC
F: GCTTCGGTGGTATGATGCTT
R: CCACAGGCTTTTCTGGTGAT
F: TCACCACCATGGAGAAGGC
R: GCTAAGCAGTTGGTGGTGCA

Size (bp)
73
126
86
216
262
146
206
127
133
127
299
204
212
263
194
281
232
147
176
183
217
169

Quantitative PCR
Evaluation of RNA expression utilizing qPCR was based on published methods described
previously247. In brief, after homogenizing in TRIzol reagent (#15596018, Invitrogen), RNA derived

60

from mice retinae was purified with an RNeasy mini kit (#79254, Qiagen, Inc.) and converted to
cDNA was performed using the High Capacity cDNA Reverse Transcription Kit (#4368814, Applied
Biosystems). Gene expression was assayed using PowerUp Sybr Green (#A25742, Applied
Biosystems) on the Quant Studio 3 Real-Time PCR system (Applied Biosystems Corp.). Analysis
was performed employing the delta-delta CT approach without conversion to RQ values as
described247. Primers are listed in Table 3.1.
Data analysis
Data are displayed as mean ± standard deviation. Statistical analysis was performed using
GraphPad Prism software version 9.0.0 (Graphpad Software, Inc. San Diego Ca, USA). Significant
differences between two related groups were assessed by paired Student’s t-tests. Results
returning p<0.05 were considered significant.
3.4 Results
BzATP injection increases expression of microglial genes associated with astrocyte inflammation.
We first determined if P2X7R stimulation was sufficient to increase expression of genes
that are associated with inducing astrocytes into an inflammatory state. BzATP (250 μM) or Saline
was injected intravitreally into the eyes of C57Bl/6J mice, and retinae were removed after 24 hours.
Intravitreal injections of P2X7R agonist BzATP increased retinal expression of Tnfa, Il1a, and C1qa
(Figure 3.1A).
As cytokines TNF-α, IL-1α, and C1q are implicated promoting astrocyte inflammation into
a neurotoxic reactive state230,231, we sought to determine the changes in transcripts associated with
reactive astrocytes. Retinal exposure to BzATP upregulated Pan-reactive genes (Gfap, Steap4,
Vim, Lcn2, SerpinA3N, and Aspg) (Figure 3.2A), A1-specific genes (C3, Serping1, H2T23, H2D1,
and Amigo2, but not Fkbp5 or Fbln5) (Figure 3.2B), and A2-specific genes (CD14 and Ptx3, but
not Clcf1, Emp1, Slc10a6) (Figure 3.2C).
Role of P2X7R in microglial and astrocyte inflammation after transient elevation of IOP.
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As chronic elevation of IOP has generated neurotoxic reactive astrocytes in the retina145,383,
we sought to determine the role of P2X7R with transient elevation of IOP. In preliminary work, the
IOP of eyes from C57Bl/6J or P2X7-/- was elevated for 4 hrs and examined 24 hrs later; previous
studies have pointed to robust gene expression responses at this timepoint6. IOP elevation resulted
in increased expression of Tnfa and Il1a in the retinae from C57Bl/6J mice (Figure 3.3A).
Interestingly, gene expression increases were not significant in retinae from P2X7-/- mice (Figure
3.3B). However, direct comparisons of normalized mean gene expression of Tnfa, Il1a, and C1qa
was insignificant, possibly indicated a need for a more robust sample set.
Gene expression of astrocyte inflammatory genes after transient elevation of IOP was
subsequently assayed. In C57Bl/6J mice, Nonsignificant or trending significant upregulation of Panreactive transcripts was observed (Figure 3.4A). A1-specific gene Serping1 was significantly
elevated, with trending significant upregulation of C3 and H2T23. Intriguingly, A2-specific
transcripts CD14, Ptx3, and Clcf1 were all significantly regulated. No inflammatory genes were
significantly upregulated in retinae from P2X7-/- mice (Figure 3.4B). Comparing the mean
normalized gene expression following transient elevation of IOP confirmed a reduced gene
expression of astrocyte inflammatory genes in P2X7-/- mice as compared to C57Bl/6J mice (Figure
3.4C) indicating a role for P2X7R in inflammatory responses from elevated IOP.
3.5 Discussion
The factors that link the loss of neural populations to the mechanical strain that is observed
with high IOP still remain uncertain. In patients, reduction of IOP has not proven consistent in
preserving retinal ganglion cell populations428, or maintaining visual function379. In patient samples,
and in many animal models of IOP have demonstrated that inflammation is a considerable
component of disease progression415. Recent work has pointed to a role of inflammatory neurotoxic
astrocytes in loss of neural populations230,231. New therapies targeting intermediary processes may
prove fruitful in reducing inflammation. Herein, we examined the role that P2X7 receptor plays in
elevation of microglia cytokines and inducing neurotoxic astrocytes. Direct injection of P2X7-
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selective agonist BzATP led to elevation gene expression of microglia inflammatory markers Tnfa,
Il1a, and C1qa. Additionally, stimulation of retinal P2X7 receptor led to increased gene expression
of several pan-reactive and A1-specific astrocyte genes. Transient elevation of IOP for 4 hours in
retinae of C57Bl/6J mice resulted in upregulation of Tnfa and Il1a, and upregulation of both A1and A2-specific genes. However, elevation of inflammatory markers was not observed after
elevated IOP in retinae from P2X7R-/- mice, implicating P2X7R as upstream of astrocyte
inflammation.
The impact of P2X7R stimulation on astrocyte inflammation state has not been explored.
Retinal exposure to BzATP for 24 hrs demonstrated that P2X7R stimulation results in polarization
to A1 neurotoxicity. P2X7R stimulation upregulated gene expression of complement cascade
component genes C3 and Serping1, as well as Major Histocompatibility Complex 1 (MHC I) genes
H2T23 and H2D1. CD14 is considered indicative of A2 anti-inflammatory phenotype. However, the
protein role in inflammation is complex, as it as membrane-bound CD14 acts as a co receptor for
TL4 in LPS-mediated signaling446. Interestingly P2X7R stimulation prior to LPS-TLR4 stimulation
has reduced inflammatory response in peripheral monocytes by increasing exocytosis of CD14 and
depleting its membrane-bound counterpart5. Similarly, Serping1 protein product functions as a
complement component C1 inhibitor70. In that manner, P2X7R stimulation resulted in a
neuroinflammatory state, without clear polarization. It should be noted, however, that definitions of
astrocyte polarization are contextual, and likely represent a more complex phenomenon26,101.
Transient elevation of IOP additionally resulted in expression of astrocyte inflammatory
genes. This supports work using the microbead model of chronic elevation of IOP leading to
upregulation of neurotoxic reactive astrocytes in ASCA2+ cell populations which implicates A1astrocyte reactivity in the retina145,383. In both studies, astrocyte inflammation and loss of RGCs
from elevated IOP in mice where Il1a, Tnfa, and C1qa were deleted145, indicating that gene
upregulation and cytokine release are necessary for astrocyte inflammation and RGC loss from
elevated IOP, within the model at a minimum.
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The P2X7 receptor is widely expressed, but at higher density on microglia within the
CNS189,395. However, this study did not determine the cell specific expression of the genes that
were evlauated. Many of the genes attributed to neurotoxic reactive astrocytes are implicated in
the complement pathway and antigen presentation, microglia may contribute to the pool of
upregulated genes. For example, previous work indicates that Müller glia are the primary cell
population

expressing

C3320,

but

C3

protein

expression

has

been

detected

in

microglia/macrophage populations in murine models and human patient samples of Amyotrophic
Retinal Degeneration (AMD)299 and Retinitis Pigmentosa (RP)373. As most previous work, including
specifically in models of elevated IOP, focus only on one cell population, it can be said that
astrocytes and Müller glia are contributors to gene upregulation within the retina, and are likely
polarized into a neuroinflammatory state.
Similarly, the exact contribution of microglia remains uncertain. Microglia are postulated to
be the upstream regulators of neurotoxic reactive astrocytes230. Though they are likely to be the
cell population that is the primary source of TNF-α330 and IL-1α15, cell-specific identification of these
factors in vivo has not been evaluated. In vitro, polarization of microglia with LPS led to the release
of TNF-α, IL-1α, and C1q into cell supernatants, which then polarized in vitro astrocytes into an A1
neurotoxic phenotype231. This suggests that microglia are sufficient to induce neurotoxic astrocytes.
Yet ablation of microglia with PLX5622 and subsequent application of the optic nerve crush (ONC)
model of elevated IOP did not rescue the RGC loss that was observed when microglia ablation was
not performed231. This may be due to infiltration from peripheral macrophages that are present in
CD11b+CD11c+ populations that are early contributors to inflammation in mouse models of chronic
elevated IOP383,414. However, the early timepoint (24 hrs) minimizes the chance of peripheral
monocytes to migrate into the retina. Furthermore, work has demonstrated that BzATP
administration to ex vivo retinae was sufficient to induce phenotypic activation of resident microglia,
indicating that P2X7R stimulation of resident microglia is sufficient to induce an inflammatory
response. Taken all together, the data generated in this study supports a model whereby microglial
P2X7R stimulation on microglia promotes the release of cytokines that induce neurotoxic reactive
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astrocytes (Figure 3.5). Regardless, the question of cell specific origin of Tnfa, Il1a, and C1qa
remains an important one that can be addressed with future research.
In conclusion, our results extend the role of P2X7R as a means to induce neurotoxic
reactive astrocytes, Furthermore, preliminary data indicates that transient elevation of IOP may
promote reactive astrocyte inflammation through stimulation of P2X7R.
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Figure 3.1. BzATP-injected retinae express microglia activation genes. A Retinae that were
injected with saline (Saline) or 250 μM BzATP (BzATP) increased gene expression of Tnfa,
C1qa, and Il1a after 24hrs, (n = 7 Saline and 7 BzATP-injected retinae; Paired Student’s t-test;
samples normalized to average of Saline-injected eyes). ** p<0.01, *** p<0.001.
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Figure 3.2. P2X7R stimulation leads to elevated gene expression of neurotoxic astrocyte
genes. A Transcripts of pan-reactive astrocyte inflammation are upregulated in retinae exposed
to BzATP B Astrocyte A1-specific genes C3, Serping1, H2D1, H2T23, and Amigo2 are
significantly upregulated. C Astrocyte A2-specific genes Cd14 and Ptx3 are significantly
upregulated. All data represented as paired Student’s t-test, normalized to average of Saline
eyes; n = 7 Saline and 7 BzATP-injected retinae. * p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001.
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Figure 3.3. Elevated IOP leads to upregulation of genes associated with induction of
neurotoxic astrocytes. A Elevation of IOP for 4 hrs followed with tissue harvest 24 hrs later
resulted in elevated expression of Tnfa and Il1a in retinae from C57Bl/6J mice. B Similar
elevation of IOP did not lead to significant gene expression changes in retinae from P2X7-/- mice.
Data in A, B represented normalized to average of Ctrl eyes (Paired Student’s t-test; n = 4 Ctrl,
4 IOP eyes from P2RX7-/- mice (A); n = 5 Ctrl, 5 IOP eyes from C57Bl/7J mice (B). C Relative
change in expression of Tnfa, Il1a, and C1qa in retinae exposed to elevated in IOP in C57Bl/6J
mice compared to P2RX7-/- mice. Data is represented as mean DDCT levels for each gene in
IOP-elevated C57Bl/6J retinae compared to IOP-elevated P2X7-/- retinae (n=3 genes). ** p<0.01
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Figure 3.4. Elevation of IOP leads to expression of astrocyte reactivity genes. A Elevation
of IOP for 4 hrs followed and tissue harvest 24 hrs later resulted in significant or trending
expression neurotoxic reactive astrocytes in retinae from C57Bl/6J mice. B Elevation of IOP did
not lead to significant gene expression changes in retinae from P2X7-/- mice. Data in A, B
represented normalized to average of Ctrl eyes (Paired Student’s t-test; n = 4 Ctrl, 4 IOP eyes
from C57Bl/7J mice (A); n = 5 Ctrl, 5 IOP (Steap4 n = 4 Ctrl, 4 IOP) eyes from P2RX7-/- mice
(B). C Relative change in expression of reactive astrocytes in retinae exposed to elevated in IOP
in C57Bl/6J mice compared to P2RX7-/- mice. Data is represented as mean DDCT levels for each
gene in IOP-elevated C57Bl/6J retinae compared to IOP-elevated P2X7-/- retinae (n=9 genes).
*p<0.05,** p<0.01.
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Figure 3.5. Proposed model of P2X7-medated Astrocyte Neurotoxicity. P2X7 stimulation
leads to upregulation and release of factors TNF-α, IL-1α, and C1q. Released factors induce
factors in astrocytes emblematic of A1 Neurotoxicity. Astrocytes release an unknown neurotoxic
factor that acts in concert with independent cell injury to lead to neural death.
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CHAPTER 4: THE P2X7 RECEPTOR IN MICROGLIAL CELLS MODULATES THE
ENDOLYSOSOMAL AXIS, AUTOPHAGY AND PHAGOCYTOSIS *
4.1 Abstract
Microglial cells regulate neural homeostasis by coordinating both immune responses and
clearance of debris, and the P2X7receptor for extracellular ATP plays a central role in both
functions. The P2X7receptor is primarily known in microglial cells for its immune signaling
and NLRP3 inflammasome activation. However, the receptor also affects the clearance of
extracellular and intracellular debris through modifications of lysosomal function, phagocytosis,
and autophagy. In the absence of an agonist, the P2X7receptor acts as a scavenger
receptor to phagocytose material. Transient receptor stimulation induces autophagy and
increases LC3-II levels, likely through calcium-dependent phosphorylation of AMPK, and
activates microglia to an M1 or mixed M1/M2 state. We show an increased expression of
Nos2 and Tnfa and a decreased expression of Chil3 (Ym1) from primary cultures of brain microglia
exposed to high levels of ATP. Sustained stimulation can reduce lysosomal function in microglia
by increasing lysosomal pH and slowing autophagosome-lysosome fusion. P2X7 receptor
stimulation can also cause lysosomal leakage, and the subsequent rise in cytoplasmic
cathepsin B activates the NLRP3 inflammasome leading to caspase-1 cleavage and IL-1β
maturation and release. Support for P2X7 receptor activation of the inflammasome following
lysosomal leakage comes from data on primary microglia showing

IL-1β release

following

receptor stimulation is inhibited by cathepsin B blocker CA-074. This pathway bridges
endolysosomal and inflammatory roles and may provide a key mechanism for the increased
inflammation found in age-dependent neurodegenerations characterized by excessive lysosomal
accumulations. Regardless of whether the inflammasome is activated via this lysosomal leakage
or the better-known K+-efflux pathway, the inflammatory impact of P2X7 receptor stimulation

* Some text and figures taken or modified from Campagno, K. E. & Mitchell, C. H. The P2X7
Receptor in Microglial Cells Modulates the Endolysosomal Axis, Autophagy, and Phagocytosis.
(2021) Front Cell Neurosci 15, 645244.
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is balanced between the autophagic reduction of inflammasome components and their
increase following P2X7-mediated priming. In summary, the P2X7receptor modulates clearance of
extracellular debris by microglial cells and mediates lysosomal damage that can activate the
NLRP3 inflammasome. A better understanding of how the P2X7receptor alters phagocytosis,
lysosomal health, inflammation, and autophagy can lead to therapies that balance the inflammatory
and clearance roles of microglial cells.
4.2 Introduction
Microglia act as the innate immune effector cells of the central nervous system (CNS) 123,209
and their contribution to inflammatory signaling pathways between neurons, astrocytes and other
components of neural tissue largely sets the magnitude of the immune responses. Although
microglia constitute a relatively small number of cells in the CNS
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, their position as the primary

defensive cells in neural systems places them at the crossroads of health and disease. The
inflammatory responses mediated by microglial cells are regulated by multiple stimuli that help
ensure an appropriate response. Extracellular ATP acting at the P2X7 receptor is widely recognized
as a pivotal player in microglial signaling for triggering the release of neurotrophic factors, cytokines
such as IL-6, and the activation of the NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3)
inflammasome 199.
In addition to their role in inflammatory signaling, microglial cells make major contributions
to the clearance of material from extracellular space. Their ability to phagocytose and degrade
apoptotic cells, bacteria and engulfed synaptic material contributes to neural homeostasis

30,300

.

Furthermore, the dysfunctional clearance of proteins and lipids by microglia is increasingly
implicated in neurodegenerative disorders. For example, undegraded myelin and lipid droplets
have been observed within microglia from aging models 266,350. The incomplete removal of amyloid
beta (Aβ) deposits contributes to waste accumulation and “microglial exhaustion” in pathologies
such as Alzheimer’s disease 388,389. These observations suggest that defective clearance of waste
material by microglia may contribute to the mechanisms underlying some age-related
neurodegenerations.
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The multiple steps required for the phagocytosis and degradation of extracellular waste
material by microglial cells are tightly coordinated. Several lines of evidence suggest the P2X7
receptor is involved in regulating microglial clearance, including effects on phagocytosis,
autophagy, and lysosomal function. This review examines the evidence for the role of the P2X7
receptor in regulating these steps and highlights the role of the P2X7 receptor in modulating both
the clearance and inflammatory components of microglial function.
4.3 Extracellular ATP and P2X7 receptors
Purinergic signaling pathways evolved early, and the ubiquitous presence of high
cytoplasmic adenosine triphosphate (ATP) levels, combined with multiple pathways for ATP
release, ensured widespread use of ATP as an extracellular transmitter. ATP can be released
physiologically through ion channels or from vesicles loaded with ATP 21,95. Increased extracellular
ATP is often associated with pathological stress; this rise in extracellular ATP concentration can
result from an upregulation of channel and vesicular release pathways, in addition to the release of
cytoplasmic ATP upon cell rupture. Signaling is largely mediated by stimulation of ionotropic P2X
or metabotropic P2Y receptors by ATP, the dephosphorylated nucleotide adenosine diphosphate
(ADP) or pyrimidine analogues 59. Adenosine produced by the subsequent dephosphorylation can
act at a distinct set of metabotropic receptors, adding to the complexity. This also emphasized the
role of extracellular dephosphorylating enzymes in coordinating purinergic signals.
While most cell types possess some combination of purinergic receptors, purinergic
signaling plays a particularly important role in microglial cells. The P2Y12 receptor for ADP is widely
recognized as a marker for microglial cells; P2Y12 receptor expression is greatest on the ramified
processes, and stimulation makes a major contribution to chemoattractant responses of microglial
cells

277,286

. Stimulation of the adenosine A2A receptor on microglial cells contributes to the

characteristic

amoeboid

morphology

during

inflammation315.
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The ionotropic P2X7 receptor is especially relevant to immune responses in microglial cells
due to its requirement for high concentrations of ATP, its lack of inactivation, the distribution of
particular splice variants amongst immune cells, the multiple interactions of its extended
cytoplasmic tail, and its association with the opening of a large transmembrane pore 90. Receptor
opening is stimulated by levels of ATP approaching the millimolar range, several orders of
magnitude higher than required for other P2X or P2Y receptors

73

. While this was originally

interpreted to mean the receptor was only activated by large levels of ATP released following cell
rupture, the presence of the P2X7 receptor on several post-mitotic cells, combined with the
identification of pannexin channels as ATP conduits localized adjacent to P2X7 receptors, provided
for a role for the receptor in more widespread signaling scenarios

279

. Like other members of the

P2X family, binding of ATP leads to the opening of a cation-selective channel that allows Ca+ and
Na+ influx, and K+ efflux. However, in some circumstances stimulation also leads to the opening of
a pore permeable to larger macromolecules up to 900 Da; whether this pore represents a more
dilated state of the P2X7 channel or the recruitment of additional proteins such as pannexin
channels remains unresolved, despite intense investigation

91

. The lack of P2X7 channel

inactivation in the continued presence of agonist has been attributed to the palmitoylated C-cys
anchor retaining the gate in the open position

273

. This lack of inactivation makes regulation of

agonist levels critical for both initiating the signal and also shutting it down in a timely manner; there
are parallels with the NMDA channel for glutamate in both the central role in signaling and the
damage following overstimulation of both channels. The human P2X7 receptor possesses multiple
splice variants, and the variant including the large 240 AA carboxy tail is usually associated with
immune cells; this carboxy tail contains many of the binding sites associated with complex
inflammatory interactions 75,189,210.
While the P2X7 receptor was originally referred to as “death receptor”, more recent work
indicates the contribution of the receptor is much more nuanced, with participation in a variety of
signaling events; stimulation can even lead to proliferation in microglial cells

28

. These varied

outcomes from the P2X7 receptor may be explained by differences in splice variant expression,
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agonist availability and other factors still under investigation

2,89

. While excessive stimulation can

lead to microglial cell death, the effects of the P2X7 receptor on the endolysosomal axis discussed
here usually do not lead to cellular demise, but have sustained pathological consequences for
microglial clearance instead.
4.4 Microglia, inflammation, and clearance
Microglia are morphologically plastic cells, existing in a variety of states in response to
environmental stimuli. In the “resting” state, often referred to as M0, microglia engage in a constant
sampling of their surroundings, with long ramified extensions surveying the neuronal milieu

305

.

Microglia are constantly molded by environmental cues and respond to localized differences, so
that even in the resting state the population shows great heterogeneity

222

. Once microglia are

challenged with immunomodulatory substances, they enter an “activated” state in an attempt to
maintain homeostasis. Although there is a range of “activated” states, they have traditionally been
characterized into pro-inflammatory (“classical activation”, M1) and pro-phagocytic (“alternative
activation”, M2) states 77. The M2 state itself can be subdivided into the M2a state associated with
repair/regeneration functions, the M2b state associated with immunomodulatory functions, and the
M2c state associated with an acquired deactivation phenotype

67,264,267

. Progression into these

activation states follows clear triggers; application of lipopolysaccharide (LPS) or Interferon gamma
(IFN-γ) leads to the M1-like states, application of Interleukin (IL) IL-4 or IL-13 triggers the M2a state,
ligation of immunoglobulin Fc-gamma-receptors that results in IL-12 expression, increased IL-10
secretion, and HLA-DR expression leads to the M2b state, while IL-10 is associated with the M2c
state 4. The states themselves are defined by proteomic or genetic markers, with IL-1β (Il1b) or
NOS2/iNOS (Nos2) for M1, Arg1 (Arg1) or Chil3/YM1 (Chil3) for M2a, IL-10 (Il10) or CCL1 (Ccl1)
for M2b and CD163 (Cd163), MMP8 (Mmp8), and VCAN (Vcan) for M2c

33,65,67,255,264,267,390,424

.

However, recent investigations indicate this categorization is far too simplistic, and the different
microglial states are better represented as a spectrum of combinations 243,288. That said, the basic
divisions between microglial states associated with increased inflammatory signals and those
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linked to increased phagocytosis are important to consider when interpreting the varied effects of
the P2X7 receptor, and would benefit from a more thorough examination in the future.
The functional responses associated with the various microglial states usually help
maintain the optimal activity of the neural tissue, a connection that can by overlooked when
research is focused on pathology. However, the central role of microglia in coordinating the immune
responses can lead to aberrant behavior upon excessive stimulation or impaired restraint. Microglia
dysfunction has been implicated in several disease states, including schizophrenia 406, autism 228,
ischemic stroke 193, traumatic brain injury 244, Alzheimer’s disease 389, Parkinson’s disease 108 and
frontotemporal dementia

159

. Understanding how to maintain the beneficial activities of microglia

while limiting their destructive actions remains a key challenge, and the P2X7 receptor is likely to
contribute to the balance with its central role in coordinating both inflammation and clearance.
The effects of the P2X7 receptor on microglial clearance are less well studied than those
on inflammation, and throughout this review, results obtained from primary and cultured microglial
cells are supplemented by work on macrophages and monocytes. While microglial cells share
many features with their peripheral cousins the macrophages, including recognition through the
widely used markers Iba1 or Cx3CR1, microglia differ from peripheral macrophages224,337. For
example, microglia differ from macrophages in protein expression 25,54, turnover 11,220, inflammatory
response 48,447, and physiological regulation 261-263. Microglia originate from early myeloid progenitor
cells that migrate from the yolk sac, with minimal CNS contribution from peripheral macrophages
24,127,132

. Of particular relevance here is the increased expression of degradative lysosomal

enzymes such as dipeptidyl peptidase, tripeptidyl peptidase and Cathepsin D (CatD) in microglial
cells as compared to macrophages

263

. Also important in this regard are differences between

microglial cells from inflamed CNS and those recruited from blood-derived monocytes; the
substantial differences recently identified between these cell types implies their response to the
P2X7 receptor could well differ

39,217,439

. While the relative paucity of data from microglial cells on

how the P2X7 receptor alters clearance means that some of the information presented in this review
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has been obtained from macrophages, the reader should be aware that application of results from
macrophages to microglial cells has limitations.
4.5 P2X7 receptor and microglial states
The P2X7 receptor is widely recognized for its inflammatory actions. Stimulation of the P2X7
receptor can result in the secretion of proinflammatory cytokines IL-1β and IL-6 in many cell types
3,52,367

. Additionally, stimulation of the P2X7 receptor leads to the nuclear translocation of

transcription factor nuclear factor kappa-light-chain enhancer of activated B cells (NF-κB) which
has been demonstrated to elevate gene expression of Tnfa, Cox2, and Il1b in microglia 106. While
these markers are widely associated with the proinflammatory M1 state of microglia, the pattern of
genes activated by stimulation of the P2X7 receptor in microglial cells is likely to be complex. M2
state markers Arg1 and CD163 occurred following 15 minute stimulation with Benzoylbenzoyl-ATP
(BzATP), a selective agonist of P2X7 103, which may indicate a mixed activation state similar to what
has been observed in microglia following traumatic brain injury 288. Furthermore, isolated rat primary
microglia challenged with LPS revealed upregulated expression of gene Arg1 and its protein
product 243. A direct comparison of LPS and IL-4 challenge to primary mouse microglia indicate that
IL-4 induces an exponentially higher expression of Arg1 compared to LPS 67, however, suggesting
the response is complex. Microglial activation state and autophagy may be interrelated, with
autophagy induction polarizing microglia towards the M1 state, while induction of M2 state can itself
increase autophagy 103.
4.6 P2X7 receptors and phagocytosis by microglial cells
Phagocytosis of extracellular material is a central function of microglial cells. Materials
bound to phagocytic receptors are taken in through the phagocytic cup and delivered to the
endocytic system for pathogen destruction, degradation, or sorting

377

. Induction of the M2a state

leads to an increase in cell-specific receptors associated with phagocytosis such as CD163,
TREM2, and Dectin-1

85,204,212,303,430,450

. However, expression of phagocytosis receptors does not

necessarily correlate with increased phagocytosis, and the relationship between induction into the
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M2a state and the rate of phagocytosis is a matter of debate

265

. Induction of both M1 and M2

microglial phenotypes was found to reduce deposits of amyloid beta in vivo 404, while addition of IL4 suppressed macrophage phagocytosis of beads in vitro

287

. Stimulation of receptors such as

TREM2 and MerTK modulate microglial phagocytosis 178,307, but the relationship between the P2X7
receptor and microglial phagocytosis by microglia are more complex. For example, P2X7 receptor
expression was not upregulated with the challenge of lipopolysaccharides 338, but was upregulated
with exposure to amyloid beta (1-42) 275, suggesting P2X7 expression is a specific response.
One of the most intriguing connections between the P2X7 receptor and phagocytosis
involves its identity as a scavenger receptor, whereby the receptor increases phagocytosis in the
absence of external agonist ATP

139-141

(Figure 4.1A). This role of the P2X7 receptor differs

considerably from other functions in that activity as a scavenger receptor is reduced when
extracellular ATP rises. For example, phagocytic uptake of non-opsonized beads by cells of the
human monocyte THP-1 cell line was reduced by blocking the receptor with antibodies against the
extracellular domain of the P2X7 receptor 139. A similar reduction in phagocytosis of E. coli bacteria
by human derived monocytes was also induced by a P2X7 receptor antibody 316. Pharmacological
support for the P2X7 receptor contribution was shown in human microglial cells when stimulation
of the P2X7 receptor with agonist BzATP reduced phagocytosis of fluorescent-tagged E. coli
bioparticles, while P2X7 antagonist A438079 reversed the effect of BzATP and enhanced
phagocytosis of these bioparticles 179. Further support for a role for the unstimulated P2X7 receptor
in phagocytosis was shown on a molecular level in experiments where siRNA knockdown of the
P2X7 receptor reduced phagocytosis in the absence of agonist in isolated human monocytes, while
overexpression of the P2X7 receptor in HEK293 increased phagocytosis 139,140.
Details about the mechanisms of P2X7 as a scavenger receptor show a complex pattern.
Extracellular residues 306-320 of the P2X7 receptor were shown to bind to beads, bacteria and
apoptotic cells 140. Intracellular regions of the P2X7 receptor are bound to non-muscle myosin heavy
chain IIA (NMMHC IIA) and thus the cytoskeleton 138,139, consistent with a pathway for phagocytosis
of material into the cell. The addition of ATP led to dissociation of NMMHC IIA from the P2X7
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receptor and reduced phagocytosis with roughly the same kinetics as channel gating, suggesting
a common link. Overexpression of NMMHC IIA reduced the pore-opening activity that occurred
with P2X7 receptor agonist presentation, reinforcing the notion that the receptor may switch
between its phagocytic and conductive identities 138. However, P2X7 receptor selective antagonists
blocked pore formation but not phagocytic activity in human monocytes

316

, indicating that

phagocytosis is driven by the closed state of the receptor, and antagonist binding sites are distinct
from the phagocytic targets

141

. This suggests these P2X7 antagonists can block channel activity

without affecting phagocytosis, a useful selection trait if the goal is to reduce the balance between
inflammatory activity and phagocytosis

110

. Transient stimulation of the P2X7 receptor in human-

derived microglia decoupled the receptor from the cytoskeleton and eliminated its ability to
phagocytose bioparticles while also activating caspase-1

138,139

. Overall, the ability of the P2X7

receptor to enhance phagocytosis in the absence of extracellular ATP presents a critical step in
understanding how the receptor manipulates microglial clearance of extracellular debris. Moreover,
P2X7 receptor phagocytic activity is likely restricted to microglia, as phagocytosis by human
monocyte-derived macrophages was inhibited with a glycoprotein-rich fraction of serum137 (Gu et
al. 2012). Readers are directed to the excellent review by Gu and Wiley for more details about the
P2X7 receptor as scavenger receptor 141.
While the ability of the P2X7 receptor to act as a scavenger receptor in the absence of an
agonist is strongly supported by the evidence above, it should be noted that not all experimental
findings agree with this concept. For example, recent work in murine bone marrow-derived
macrophages (BMDMs) suggests that stimulation of the P2X7 receptor enhances uptake of
pHRodo-tagged bacterial bioparticles, as uptake was reduced following exposure to P2X7 receptor
inhibitor A740003 and by reduction of extracellular ATP with the hydrolyzing enzyme apyrase

453

;

phagocytosis was not inhibited with antagonists AZ10606120 and A438079, however 8. Whether
these differences indicate a characteristic of BMDMs or just experimental deviation remains to be
determined.

79

4.7 P2X7 and regulation of lysosome pH and autophagosome maturation
Lysosomes are membrane bound organelles with an acidic lumen that are responsible for
the degradation of extracellular materials delivered through the endocytic pathway, or of
intracellular materials delivered via autophagy. Degradation is accomplished by several
intraluminal hydrolases, whose enzymatic activity is optimally at low pH levels

386

. In addition to

being necessary for optimal degradative activity, a low lysosomal pH is important for maintaining
the electrical potential across the lysosomal membrane, the transport of signaling molecules stored
in lysosomes such as Ca2+ and ATP, and for the fusion of the lysosomal membrane with incoming
autophagosomes and endosomes

322,435

. Elevation of lysosomal pH reduces degradation of

phagocytosed material in numerous cell types
protein degradation

206

357

and leads to autophagic backup and reduced

, making the restoration of lysosomal pH a key target for amelioration of

diseases of accumulation 144.
The ability of P2X7 receptor stimulation to elevate lysosomal pH in numerous cell types
including microglia, has important implications for clearance (Figures 4.1B,C). The P2X7 receptor
deacidified lysosomes in microglial cells; stimulation of the MG6 microglia cell line with ATP 402 or
the BV2 microglial cell line with P2X7 receptor agonist BzATP 365 elevated lysosomal pH. The ability
of P2X7 receptor antagonists to prevent this de-acidification supported a role for the P2X7 receptor
in this rise in lysosomal pH. It should be noted, however, that P2X7 receptor stimulation of
macrophages infected with bacteria acidified lysophagosomes 104.
The relatively high lysosomal pH of microglial cells under baseline conditions differs from
peripheral macrophages and other cells, with a reported value of six as compared to 4.5-5 in most
cell types

263

. However, the lysosomal pH in microglia is dynamic, and several pathways are

involved in lowering the luminal pH in preparation for degradative activity. For example, stimulation
with microglial activating compound Macrophage Colony Stimulating Factor (MCSF) or LPS
lowered lysosomal pH and enhanced degradation of protofibrillar amyloid beta (fAβ)

263

. MCSF

putatively polarizes microglia to the M2 state while LPS polarizes them towards the M1 state 65,169.
This study also demonstrated that forskolin lowered lysosomal pH and increased fAβ degradation,
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and the enhanced degradation induced by MCSF was blocked by inhibition of protein kinase A or
chloride transport, consistent with cyclic adenosine monophosphate (cAMP) and chloride
contributing to lysosomal acidification. The movement of chloride transporter CLC-7 into the
lysosomal membrane to enact Cl- counterion transport was subsequently identified as a key
mechanistic step in luminal acidification 261. Future experiments are needed to determine whether
baseline lysosomal pH differs in microglia of the pro-phagocytic M2 state, and whether the rise in
lysosomal pH associated with P2X7 receptor stimulation is altered in this subset of cells.
A rise in lysosomal pH will usually reduce rates of degradation or autophagy. After
extracellular debris is engulfed into the cell via phagocytosis, it moves through a membrane
enclosure called an autophagosome, which eventually binds to and fuses with the lysosome for
hydrolase-mediated degradation. There are suggestions that stimulation of the P2X7 receptor may
reduce autophagosome-lysosome fusion to further reduce bacterial clearance. ATP reduced the
fluorescence signal in MG6 microglial cells that had phagocytosed pHrodo-BioParticles

400

; as

pHrodo-BioParticles fluoresce brighter in the lower pH levels of lysosomes, this implied a reduced
delivery to the lysosomal lumen, although this is also consistent with a de-acidification of that
compartment. Furthermore, exposure to 2.5 mM ATP for 4 hours resulted in detection of transferrin
receptor protein, the intermediate form of endolysosomal protease CatD and autophagosomal lipid
marker microtubule-associated protein 1A/1B-light chain 3-II (LC3-II) into the supernatant,
consistent with incomplete autophagosome-lysosome maturation and elevated secretion into the
extracellular space 402 via a non-classical secretory pathway 98. Lysosome destabilization can also
lead to release of lysosomal cathepsins into the cytoplasm

295

. Intracellular cathepsin B (CatB) is

known to promote cleavage of cytokine IL-1β via caspase 1 after stimulation of the P2X7 receptor
(Figure 2). Furthermore, CatB activity can polarize microglia closer to M1, with microglia isolated
from hippocampi after hypoxia/ischemia expressing significantly higher levels of Nos2, Tnfa, and
IL1b not observed in those from CatB-/- mice 304.
The above contrasts with in vitro studies of human and mouse macrophages also suggest
that the P2X7 receptor can enhance phagosome-lysosome fusion and increases degradation of

81

bacteria in a calcium and phospholipase D (PLD)-dependent manner

80,82,215,384

. Mouse

macrophages that internalized Mycobacterium bovis Bacille Calmette-Guérin (BCG) followed by
exposure to 3mM ATP for 4 hrs showed increased colocalization between BCG and lysosome
marking-dye Lysotracker Red 104. P2X7 receptor stimulation reduced the viability of Mycobacterium
tuberculosis in primary human macrophages and THP-1 derived macrophages, dependent upon
Ca2+ influx and activation of PLD

214,215

. Inhibition of the PLD was independent of Ca2+ influx, and

correlated with the reduction of phagosome-lysosome fusion. However, internal calcium stores
were involved with the loss of internalized M. bovis that were associated with high levels of
extracellular ATP 384. These differences between effects of the P2X7 receptor on phagocytosis by
macrophages versus microglia again stress the need for further examination on microglia alone.
4.8 Manipulation of autophagy by the P2X7 receptor
Autophagy is the process by which intracellular material is identified, packaged, and
trafficked for lysosomal degradation, and several lines of evidence suggest the P2X7 receptor can
modulate the autophagy process (Figure 4.1). Autophagy is normally prevented by the mammalian
target of rapamycin 1 (mTOR1); inhibition of mTOR by AMP-activated protein kinase (AMPK) can
thus initiate autophagy 162,301. Recruitment of LC3 to membranes leads to the formation of nascent
autophagosomes, and increased clustering of the membrane-bound phosphatidlyethanoliamineconjugated LC3-II is a common marker for autophagy initiation

206

. Autophagy, by definition,

focuses on processing material produced within microglial cells, but autophagic and phagocytic
pathways run in parallel. While autophagy
inflammation

391

327

, phagocytosis

371,377

and their intersection with

within microglia have been individually reviewed, the specific effects of P2X7

receptor stimulation on the autophagic pathway in microglia merit special attention.
Transient stimulation of the P2X7 receptor with ATP or BzATP elevates LC3-II levels in
isolated primary mouse microglia, with LC3-II returning to basal levels 4 hrs after receptor
stimulation

402

. A similar rise in LC3 was found in the MG6

402

and BV2

365

microglial cell lines.

Receptor involvement is supported by a reduced LC3-II response to stimulation in microglial cells
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from P2X7-/- mice and in the presence of P2X7 antagonists. The rise in LC3-II was greater in
microglial cells from the SOD1-G93A mouse model of Amyotrophic Lateral Sclerosis (ALS) than
the wild type, and peaked 15 min after agonist presentation 103.
Elevation of LC3-II can represent autophagic induction or autophagic backup 206; the ability
of the P2X7 receptor to elevate lysosomal pH, combined with the autophagic reduction that
accompanies lysosomal de-acidification

197

, demands particular care when investigating how the

P2X7 receptor increases LC3-II levels. Levels of LC3-II were increased further when proton pump
inhibitor Bafilomycin A1 was given concurrently with BzATP

103

; while this is a classical test to

distinguish between autophagy induction and inhibition, the relatively small increase, combined
with the absence of absolute pH measurements, does not rule out an effect of lysosomal deacidification on rising LC3-II levels. The BzATP-mediated rise in LC3-II was dependent upon
extracellular calcium in microglia and THP monocytes

32,402

, but extracellular calcium was also

necessary for lysosomal deacidification 142. However, additional observations support the ability of
the P2X7 receptor to raise LC3-II by inducing autophagy, independent of its effects on lysosomal
pH.

In microglia derived from the superoxide dismutase 1 (SOD1)-G93A mouse model of

Amyotrophic Lateral Sclerosis (ALS), sequestosome-1 SQSTM1/p62 levels were reduced by 15
min BzATP but increased by a sustained stimulation with BzATP for 6 hours 103. As SQSTM1/p62
normally binds to cargo targeted for autophagic degradation by the lysosome, and is itself
degraded, p62 accumulation is a standard indicator of autophagic backup due to a reduced
lysosomal function

205

. However, SQSTM1/p62 is a multifunctional protein implicated in several

cellular interactions such as adipogenesis, nutrient sensing, oxidative stress reactions though
nuclear factor erythroid 2-related factor (Nrf2), and regulation of NF-κB. Additionally, both Nrf2 and
NF-κB have transcriptionally upregulated expression of SQSTM1/p62 331,353. As such, the complex
time course linking the P2X7 receptor to p62 may reflect involvement of pathways in addition to
degradation.
The activation of the AMPK pathway following stimulation of P2X7 receptors also provides
support for autophagic induction by the P2X7 receptor, given the role of AMPK in regulating
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autophagy induction 201. For example, BV2 cells stimulated with BzATP showed an elevation of pAMPK, consistent with autophagy induction

365

. LC3-II protein levels were reduced with siRNA

against AMPK, AMPK inhibition with Compound C, or addition of mitochondrial antioxidant
MitoTEMPO. The activation of AMPK by calcium-sensitive calcium/calmodulin-dependent protein
kinase kinase beta (CaMKKβ)

36

may link calcium influx through the P2X7 channel and AMPK

activation. The demonstration of rapid phosphorylation of mTOR after BzATP application also
supports autophagy induction downstream from AMPK-activation

103

. Whether P2X7 receptor

signaling leads to canonical inhibition of mTOR, activation of AMPK, or additional pathways
requires further clarification. Future investigations must control for the effect of P2X7 receptors on
lysosomal pH, and the considerable feedback systems mediated by Transcription factor EB (TFEB)
that are activated by this rise in pH

451

. However, the identification of intersections between the

P2X7 receptor and autophagy pathways is an active field of investigation in microglial research and
multiple targets should soon emerge.
4.9 Effect of priming and autophagy on P2X7 receptor mediated inflammatory responses
While this review is focused on how the P2X7 receptor modifies microglial clearance,
autophagic clearance can also modulate the impact of the P2X7 receptor on inflammation. The
P2X7 receptor is well known for its association with increased inflammatory signals and cytokine
release (Figure 4.2); its interaction with the NLRP3 inflammasome is perhaps the most widely
recognized

90

, and the P2X7 receptor was the most potent activator of the NLRP3 Inflammasome

in N13 microglial cells 114. The NLRP3 inflammasome is a multimeric compound consisting of NOD, LRR- and pyrin domain-containing protein 3, the apoptosis-associated speck-like protein
containing caspase recruitment domain (ASC), and procaspase-1

396

. The resulting release of

master cytokine IL-1β can influence many immune signals, and the inflammasome is tightly
regulated to reflect its central role. In the first “priming” step, the availability of inflammasome
components is controlled. In the second step, these components assemble together to form the
inflammasome itself, resulting in sequential cleavage of caspase 1 and then cytokines IL-1β and
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IL-18 into their mature forms. These mature cytokines exit the cell through the cleaved gasdermin
D pore, enabling cytokine release into extracellular space where they initiate a variety of
inflammatory responses. The efflux of K+ from the cell is a key signal to assemble component
proteins into the inflammasome, and this efflux is frequently associated with opening of the P2X7
receptor 196,294,396.
While the P2X7 receptor is closely associated with the secondary activation stage of the
NLRP3 inflammasome, reports also link it to the first priming phase. Priming is often initiated
experimentally with the Toll-Like Receptor 4 agonist LPS, which leads to translocation of
transcription factor NF-κB to the nucleus, resulting in the transcription of inflammasome
components

191

. However, a number of studies suggest that the P2X7 receptor can also fulfill the

priming step, initiating translocation and IL-1β transcription itself. N9 mouse microglia cells exposed
to ATP or BzATP demonstrated NF-κB activation, though the response was delayed when
compared to LPS-mediated activation

106

. This study also demonstrated that the NF-κB/DNA

complex induced by P2X7 receptor signaling differed from that induced by LPS, in that ATP induced
a p65 homodimer, rather than the p65/p50 heterodimers found with LPS. Work in HEK293T cells
and the RAW264.7 macrophage cell line indicate that the P2X7 receptor also interacts with myeloid
differentiation primary-response protein 88 (MyD88), a common adaptor protein for TLRs 242. P2X7
receptor-induced NF-κB translocation has been demonstrated in osteoclasts
124

211

and osteoblasts

, suggesting that P2X7 receptor activation of NF-κB may be a common mechanism for priming

inflammasome components. In astrocytes, data showing inflammasome priming of isolated
microglial cells by the P2X7 receptor was supplemented by a role in vivo, in which increased
expression of IL-1β followed injection of BzATP, and the pressure-dependent rise in IL-1β was
absent in P2X7-/- mice 6. This ability of the P2X7 receptor activation to both prime and activate the
NLRP3 inflammasome places it in a very powerful position to regulate innate immune responses.
Numerous
inflammasome

29

studies

highlight

interactions

between

autophagy

and

the

NLRP3

; while the specific role of the P2X7 receptor is usually not involved, autophagic

degradation of inflammasome components is predicted to regulate the ability of the P2X7 receptor
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to activate the NLRP3 inflammasome. Increased autophagy is associated with decreased NLRP3
Inflammasome function in vivo in rodent microglial cells

63

, and in primary microglia cells

63,68,150

.

Autophagic degradation of inflammasome components was also suggested by studies in the BV2
cell line

150,202,366,438

, in THP-1 human macrophages

238

, and in BMDCs or immortalized bone

marrow-derived macrophages 152,394. Induction of autophagy by a small molecule reduced NLRP3
expression in microglial cells and inflammasome activation

150

. Suppressed caspase-1 activation

may lead to enhanced autophagy in microglial cells following inflammasome silencing 216. Primary
microglia derived from mice deficient in autophagy gene Beclin-1 (BECN-/-) had less colocalization
between NLRP3 and LC3 than their wild-type counterparts, and increased IL-1β levels, suggesting
that autophagic degradation can reduce the NLRP3 inflammasome response

167

. Colocalization

between ASC or NLRP3 and LAMP-1 after induction of autophagy was demonstrated in THP-1
cells

369

. Similarly, IL-1β colocalized with LC3-GFP puncta in immortalized BMDMs

152

. Deficits in

autophagy and clearance are predicted to promote P2X7-mediated inflammation, as accumulation
of lipid droplets within microglia resulted in reduced phagocytosis and increased secretion of
proinflammatory cytokines IL-1β and Tnfα after LPS challenge 266. In BMDMs, autophagy induction
increased IL-1β secretion dependent upon ATG5

99

. However, degradation of inflammasome

components through the autophagy pathway is generally expected to reduce the ability of the P2X7
receptor to initiate assembly and activation of the inflammasome in microglial cells. Overall, the
balance between the degradation of inflammasome proteins and their upregulation via priming
initiated by P2X7 receptor stimulation will influence the consequences of NLRP3 inflammasome
activation by the P2X7 receptor on microglial cells (Figure 4.2).
4.10 The P2X7 receptor activates the NLRP3 inflammasome via lysosomal leakage and
cathepsin B
A particularly important connection linking the P2X7 receptor, lysosomes and inflammation
involves the ability of the P2X7 receptor to cause lysosomal destabilization and subsequent
activation of the NLRP3 inflammasome through actions of cathepsin B. In BMDMs, destabilized
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lysosomes led cathepsin B to activate caspase-1 and cleave IL-1β for release

66

. In the THP-1

monocytic cell line, S. pneumoniae triggered IL-1β release in an ATP- and cathepsin B-dependent
manner

163

. In BV-2 cells, increased leakage of cathepsin B into the cytoplasm following BzATP

application was shown using the Magic Red assay, while inhibition of cathepsin B with CA-074
prevented the BzATP-induced cell death 365. In our studies on primary mouse brain microglial cells,
the ATP-dependent secretion of IL-1β was reduced by cathepsin-B inhibitor CA-074 (Figure 4.3).
While these findings suggest a critical mechanism by which the P2X7 receptor can activate the
NLRP3 inflammasome by disrupting lysosomal integrity, additional work is needed to understand
how receptor activation leads to lysosomal leakage and whether this is related to its ability to
increase lysosomal pH. Experiments to determine whether compromised lysosomes filled with
partially degraded waste material are more susceptible to this lysosomal leakage are warranted.
4.11 Discussion
This review article has presented emerging evidence for the role of the P2X7 receptor in
regulating clearance by microglial cells. While the contributions of the P2X7 receptor to immune
signaling are well known 3,314, its ability to modulate microglial clearance has been less well studied.
The ability of microglial cells to clear extracellular and intracellular material occurs at several key
steps including the unstimulated receptor acting as a scavenger receptor to phagocytose
extracellular material into the microglial cells,

the transient receptor stimulation enhancing

autophagy through a p-AMPK pathway and the sustained receptor stimulation elevating lysosomal
pH and reducing degradation. Given its role at the crossroads between inflammation and clearance,
the ability of the P2X7 receptor to activate the NLRP3 inflammasome following lysosomal leakage
is particularly relevant. Also, regulating the availability of inflammasome components by balancing
their decrease through autophagy with their increase through priming has particular relevance as
the P2X7 receptor can itself increase priming. We propose the effects of the P2X7 receptor on
clearance pathways in microglia are as significant as its effects on inflammatory signaling. Given
that impaired clearance by microglial cells is increasingly implicated in the pathogenesis of
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neurodegenerative diseases

12

, regulation of this clearance by the P2X7 receptor warrants further

investigation, and identifies potential points of intervention.
Given the receptor involvement in both clearance and inflammation, several points of
particular relevance emerge. First, the ability of the P2X7 receptor to act as a scavenger receptor
offers several new directions for therapeutics 110,141. Because this role requires the absence of an
agonist, reducing extracellular ATP levels may provide the double benefit of increasing
phagocytosis while reducing inflammation. Overexpression of intracellular binding protein NMMHC
IIA reduced P2X7 receptor pore opening, suggesting that shifting the receptor towards this
phagocytic role may also reduce its cytotoxic actions.
Second, the relatively high baseline level of pH in the lumen of microglial lysosomes implies
that regulation of this pH is a powerful mechanism through which external and internal signals can
increase clearance. Given that stimulation of the P2X7 receptor raises lysosomal pH, pH may be
lowered by receptor antagonists, or by reducing levels of agonist ATP by increasing enzymatic
degradation of extracellular ATP and blocking ATP release through sites like pannexins. Elevation
of cAMP and chloride channel function lowered lysosomal pH in microglial cells 261,263, identifying a
potential pathway to enhance clearance. Our work indicates the elevation of cAMP and PKA can
acidify compromised lysosomes in epithelial cells

237

, and that stimulation of plasma membrane

receptors linked to stimulatory G proteins, such as the dopamine D5 receptor, can lower lysosomal
pH and increase the clearance of phagocytosed waste by impaired lysosomes

143

. Increased

clearance can also be induced by stimulating the cystic-fibrosis transmembrane conductance
regulator (CFTR) chloride channel localized to the lysosomal membrane

236

, or by acid

nanoparticles transported to the lysosomal lumen 13,246. Antagonists targeted to the P2Y12 receptor
were recently shown to lower lysosomal pH and improve clearance; of note, oral delivery of the
FDA–approved antagonist ticagrelor (Brilinta) lowered lysosomal pH and was protective in a mouse
model of neurodegeneration

248,249

. Whether this drug can cross the blood-brain barrier to reach

microglial cells, and whether it will interfere with other microglial functions regulated by the P2Y12

88

receptor remains to be determined. However these studies provide a proof of concept for
pharmacologic restoration of an acidic lysosomal lumen to enhance clearance.
Third, the ability of the P2X7 receptor to activate the NLRP3 inflammasome following
lysosomal leakage of cathepsin B identifies another pathway through which limiting P2X7 receptor
stimulation may be of benefit. Given that lysosomal accumulations and inflammatory signaling are
both emerging as key steps in aging-dependent neurodegenerations, it would be interesting to see
whether leakage of cathepsin B occurs more frequently from compromised lysosomes, and whether
this becomes a dominant pathway to NLRP3 inflammasome activation in aging microglial cell.
Finally, manipulating the balance between increasing levels of inflammasome components
through priming and decreasing them following their autophagic removal will have a considerable
impact on the immune signals emerging from the microglial cell. In this regard, the ability of the
P2X7 receptor to trigger both the stage one “priming” of the inflammasome as well as the stage two
“activation” phase suggests the P2X7 receptor, and its agonist extracellular ATP, have important
consequences for the neuroinflammatory environment. The autophagic degradation of
inflammasome components represents an “anti-priming” and emphasizes how the ratio of
increasing and decreasing relevant inflammasome proteins can control the gain on the
inflammasome responses triggered by the P2X7 receptor, including those activated by lysosomal
leakage.
While some therapeutic options of P2X7 receptor inhibition have been explored 52 a deeper
understanding of the intersection between the P2X7 receptor, clearance and inflammation will assist
treatments for neurodegenerative diseases in which both problems present. In age-related macular
degeneration, where increased accumulations and loss of microglia clearance occur, shifting the
P2X7 receptor away from its inflammatory contributions and towards its scavenging role may prove
advantageous

110,418

. In Alzheimer’s disease, aged microglia incompletely digest amyloid beta

plaques, increasing local inflammation and pathogenesis

157,389

. The detrimental effects of

Rapamycin to neurons in preclinical models of Alzheimer’s disease after plaque deposition (when
clinical diagnosis would likely occur) illustrate the complexity of manipulating a system as tightly

89

regulated as autophagy

62,190

, and stress the need for better understanding and a more nuanced

approach. Finding therapeutic modalities that ameliorate autophagic reduction, or ones that can be
targeted away from neurons, is crucial. In conditions of trauma such as spinal cord injury that are
accompanied by elevated ATP and autophagic dysregulation

120,225

, the modulation of microglia

activation state has been proposed to enhance repair 4,169,208. However, treatment timing is critical,
as transient P2X7 receptor stimulation may enhance autophagy and promote M2a microglia, while
sustained stimulation can inhibit autophagy and promote proinflammatory M1 microglia 103,183. The
P2X7 receptor plays a complex role in microglial cells in balancing clearance with inflammatory
signals; deeper mechanistic investigations may reveal more specific therapeutic approaches.
These above observations come with multiple caveats, and there remain some
inconsistencies. For example, microglial responses differ from those in macrophages on several
levels, such as the effect on phagosome-lysosome fusion. As many of the findings come from in
vitro experiments, even results obtained from “microglial” cells can vary with the use of cell lines or
primary culture. In vitro microglia have been demonstrated to lose transcriptional identity in as little
as 8 days after isolation 24. With a cell type so sensitive to extracellular environments, even small
changes in the protocol can alter responsiveness. In addition, microglial cells in vitro are removed
from the challenges of the neurodegenerative environment, and their need to phagocytose waste
material, along with the presence of accumulating waste material, will be altered significantly.
Closer attention to the effect of the microglial state on responses to the P2X7 receptor is also
needed.
In summary, the P2X7 receptor can modulate both inflammatory and clearance pathways
in microglial cells. Reducing extracellular ATP levels to shift the receptor from an inflammatory
trigger to a scavenger receptor will likely be of benefit in neuroinflammatory diseases associated
with increased waste material. Limiting conditions in which receptor stimulation leads to lysosomal
leakage will also help reduce NLRP3 inflammasome activation. The P2X7 receptor makes a
complex contribution to microglial function, and greater attention in future experiments to attributes
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such as microglial polarization and

lysosomal waste accumulation will help clarify these

interactions.

91

4.12 Figures

Figure 4.1. P2X7 receptor modulation of clearance pathways in microglial cells. A Under
control conditions when extracellular ATP levels (ATP0) are too low to activate the P2X7
receptor, it acts as a scavenger receptor to aid in the phagocytosis of extracellular waste. The
luminal pH of lysosomes in microglial cells is sufficiently acidic (green) to enable efficient
degradative enzyme activity. B Following transient stimulation with high concentrations of ATP0,
the P2X7 receptor no longer acts as a scavenger receptor. Autophagy is stimulated, shown by
a transient rise in levels of autophagosomal lipid marker microtubule-associated protein 1A/1Blight chain 3-II (LC3-II). Material is degraded and microglia express genes and proteins
associated with a mixed M1/M2 activation state. C A more prolonged stimulation of the
P2X7receptor leads to an elevated lysosome pH (red), with autophagosomal contents being
delivered extracellularly instead of to the lysosome. Markers of accumulation, including LC3-II
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(green) and sequestosome-1 (SQSTM1/p62; blue) are elevated. Microglia express genes and
proteins associated with an M2 activation state.
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Figure 4.2. Inflammasome activation by the P2X7 receptor and the balance between
priming and autophagic degradation of inflammasome components. Stimulation of the
P2X7 receptor triggers the assembly and activation (step #2) of the NLRP3 inflammasome
following efflux of K+ through the open channel (blue arrow), eventually leading to cleavage of
pro IL-1β (red star) into the mature form and release through the gasdermin D pore (blue). The
P2X7 receptor can also activate the NLRP3 inflammasome and subsequent IL-1β release by
raising cytoplasmic cathepsin B (CatB), following its initiation of lysosomal leakage through an
unknown mechanism (purple arrows). P2X7 receptor stimulation can prime inflammasome
components via NF-κB (step #1, red arrow) and increase available inflammasome components.
Component levels can also be decreased following autophagic degradation (green arrow),
limiting the inflammatory potential of P2X7 receptor stimulation. The balance between priming
and autophagic degradation will influence the inflammatory impact of P2X7 receptor stimulation.
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Figure 4.3. ATP-dependent IL-1β release from primary microglial cells involves cathepsin
B. A Purity of primary mouse brain microglia cultures shown with high staining for marker Iba1
(red) and low staining for astrocytic marker GFAP (green). B Primary microglial cultures
increased expression of Nos2 with 4 hours exposure of LPS but not IL-4, as expected for
microglial cells polarized into the M1-state (****p<0.001). Exposure to 1 mM ATP for 4 hours
increased expression of Nos2 (****p<0.001) and Tnfa (**p=0.0042) and decreased expression
of Chil3 (*p=0.014) as compared to control (Ctrl) using quantitative PCR. C Evidence of
functional P2X7 receptors in primary murine microglial cells indicated by the robust, reversible
and repeatable elevation of cytoplasmic calcium when briefly exposed to 100µM BzATP (line);
cells were loaded with Ca2+ indicator fura-2. D. Release of cytokine IL-1β triggered by exposure
to 1 mM ATP for 1 hour was reduced by cathepsin B inhibitor CA-074 (10µM). Microglial cells
were primed with 500 ng/ml LPS for 4 hours and IL-1β was measured with an ELISA.
Approaches as described previously233,247,367. All work was approved by the University of
Pennsylvania IACUC.
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CHAPTER 5: CONCLUSION AND FUTURE DIRECTIONS
5.1 General conclusions
In this dissertation, we expand upon the role that P2X7 receptor has on microglia and
astrocytes within the retina. Results from Chapter 2 implicate P2X7 receptor signaling in microglial
morphological alterations, and activation into a mixed classical/alternative state with data derived
from in vivo retinal injections and in vitro manipulations of cultured microglia. Elevation of intraocular
pressure (IOP) resulted in similar morphological and molecular changes, and results that were
dampened in retinae from P2X7-/- mice. Loss of retinal ganglion cells (RGCs) was observed after
transient elevation of IOP in C57Bl/6J mice, and those losses were reduced in retina of P2X7-/mice. Chapter 3 results revealed that direct stimulation of P2X7R in the retina increased the
expression of genes Tnfa, Il1a, and C1qa, and induced gene expression indicative of a state of
neurotoxic astrocytes. Preliminary data whereby transient IOP elevation applied to C57Bl/6J
retinae elevated gene expression of Tnfa and Il1a, and trending expression of neurotoxic reactive
astrocyte genes. Inflammatory microglia and astrocyte gene expression was reduced in retinae
from P2X7-/- subjected to elevated IOP, as compared to C57Bl/6J retinae. A literature review that
comprises Chapter 4 demonstrates that microglial P2X7R signaling reduces P2X7R scavenger
receptor activities, and transiently induces autophagy, while prolonged stimulation points to
evidence of autophagy inhibition. Furthermore, original data suggest that stimulation of P2X7R in
isolated brain microglia compromises the lysosome and leads to release of lysosomal cathepsin B
(CatB), which promotes the expression of cytokine IL-1β. As microglial cell state influences
phagocytic receptor expression, modulation of cell state into a less inflammatory phenotype may
promote phagocytosis. In this, we will discuss the implications of this work in detail, point to
limitations in this research and outline future experiments that will elucidate the role that microglial
P2X7R plays in retinal health and disease.
5.2 Activation of microglia is an early event after elevation of IOP
Data presented in Chapter 2 support the hypothesis that P2X7R stimulation leads to
inflammatory activation of microglia and contribute to loss of retinal ganglion cells. We observed
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that injection of P2X7R agonist BzATP into the retina for 24 hrs resulted in the elevation of
expression of microglia marker Iba1, retraction of processes as determined through Sholl analysis,
as well as elevated expression of pro-inflammatory genes Nos2 and Tnfa and anti-inflammatory
genes Arg1 and Chil3 all in concert with microglia activation (Figure 2.1). BzATP-induced elevation
of Iba1 expression correlated with scoring of activation by trained observers (Figure 2.1), lending
strength to the multiple methodologies we employed. Elevation of IOP for 4 hrs followed by tissue
harvest 24 hrs later additionally led to activation of microglia, increased pro- and anti-inflammatory
gene expression (Figure 2.5), and loss of RGCs in retinae of C57Bl/6J mice, but not P2X7-/- mice
(Figure 2.7). Furthermore, cultured microglia exposed to BzATP for a brief period (<3 min) retracted
processes indicating that P2X7R stimulation alone is sufficient to lead to activation of microglia
(Figure 2.4, S2.4). Taken all together, microglia activation is an early event and may contribute to
the loss of RGCs that arises from elevation of IOP.
The work in Chapter 2 supports prior work pointing to microglia activation preceding RGC
loss in other mouse models of glaucoma that utilize the elevation of IOP. In the DBA/2J genetic
model, microglia activation was detected at 1 month, prior to the onset of RGC degeneration. In
models of rat Chronic Ocular Hypertension (COH), where pressure is elevated after cauterization
of episcleral veins (ECV), elevated Iba1 or CD68 expression was detected after several days94,298,
prior to loss of RGCs. Elevation of IOP to 90 mm Hg in rat retinae increased expression of microglial
activation marker CD68 as well, the effects of which were inhibited by purinergic receptor blocker
OxATP, implicating a role of ATP392. The observations that microglia activate with transient
elevation of IOP expands upon previous literature to further implicate microglial activation as an
early event contributing to progression of progression of glaucoma.
Microglial morphological activation and gene expression were reduced in retinae from
P2X7-/- mice when compared to retinae from C57Bl/6J mice, 24 hrs after elevation of IOP (Figure
2.5). Additionally ATP levels were elevated shortly after elevation of IOP, and prior to evaluation of
morphology (Figure 2.5). While it is possible that the ATP that could contribute to activation of
microglia was derived from dying RGCs88, the time course points to extracellular ATP as originating
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elsewhere. ATP is released from pannexin hemichannels located on neurons and astrocytes that
respond to mechanical strain172,433. Future experiments utilizing this model will examine upstream
and concurrent effectors to elucidate the role of P2X7R signaling in microglial activation from
elevated IOP. Co-administration of pannexin inhibitors, such as probenecid429 with IOP elevation
will clarify the contribution of pannexin-mediated ATP release to microglial activation. If inhibition
of pannexin channels reduces microglial activation, these results will also affirm that microglial
activation precedes loss of RGCs. In addition to upstream mediators, evaluation of concurrent
factors may clarify the influences on P2X7R-mediated microglial activation in vivo. Loss of
immunoquiescent cytokines, such as Cx3CR1 ligand Cx3CL1 (fraktalkine), from elevated IOP may
contribute to inflammation in vivo. Indeed, during progression of pathology in mouse models of
Alzheimer’s disease (AD), early loss of Cx3CL1 expression contributed to microglial
activation105,133. Conversely, exogenous administration of Cx3CL1 reduced activation and
phagocytosis by activated microglia in a mouse model of Retinitis Pigmentosa443. Examination of
upstream effectors and concurrent factors that promote immunoquiescence may provide a fruitful
direction concurrent to understanding contributions P2X7-mediated inflammation, and illuminate
the mechanistic order of events that lead to loss of RGCs.
Detailed analysis of the work in chapter 2 indicates an inverse relationship where increased
microglial activation after IOP elevation correlates to loss of RGC populations. However, attribution
of loss of RGCs to microglia activation is complicated by several factors. Direct stimulation of RGC
P2X7R has led resulted in death in vitro. Furthermore, the role of P2X7R may be influenced in a
cell-specific or contextual manner. P2X7R stimulation on RGCs led to release of neuroprotective
cytokine IL-3233, while deletion of the receptor reduced function of a subset of RGCs after elevation
of IOP421. Determining the contribution of microglial activation to loss of RGC populations will
require an understanding of the cell-specific roles of P2X7R stimulation and the downstream
effectors of microglial activation and their effects on RGCs.
There is precedent for early activation contributing to loss of retinal cell populations.
Stimulation of microglial immunoquiescent receptor Cx3CR1 reduced microglial activation422,443.
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Deletion of the receptor resulted in a greater loss of RGCs after transient elevation of IOP422, and
increased cytokine secretion and phagocytosis of photoreceptor material in the Rd1 mouse model
of Retinitis Pigmentosa443. Inhibition of activation with antibiotic minocycline after elevation of IOP422
or in the DBA/2J chronic IOP model40 reduced RGC loss as well. Activation of microglia was
observed at an earlier timepoint in our work presented in Chapter 2, suggesting that microglial
contributions to RGC loss may be substantial. Furthermore, the morphological and molecular
changes observed with BzATP administration, as well as the inhibition of activation and RGC loss
observed in P2X7-/- mice implicates P2X7R stimulation as having a substantial role in microglial
activation.
The P2X7 receptor is expressed at higher density on microglia, as compared to other cell
types within the CNS75,189. Within the CNS, pathological expression of TNF-α330 and and expression
of IL-1β102 are localized microglia. Preservation of RGCs after elevated IOP was observed in
chronic models of IOP within mice whereby the genes Tnfa, Il1a, and C1qa were deleted145,383
under the hypothesis that neuron death is not driven by cytokines, but by neurotoxic reactive
astrocytes231. The data shown in Chapter 3 demonstrated upregulation of genes associated with
reactive astrocytes in retinae that were exposed to BzATP (Figures 3.1, 3.2) and preliminary data
suggest a similar response may occur following transient elevation of IOP (Figures 3.3, 3.4). This
preliminary data suggest elevation of IOP in P2X7-/- mice did not upregulate neurotoxic astrocyte
genes; confirmation would lend support to the theory that microglial P2X7R stimulation plays a key
role in the process.
The role of microglia within this model can be confirmed using microglia depletion methods,
such as administration of PLX5622. In this case, the transient elevation of IOP model that was
utilized to develop these data will prove useful. Chronic microglia depletion (>30 days) in mature
mouse retinae led to photoreceptor synapse loss in the OPL425 providing for confounding effects
for depletion of microglia in chronic models of IOP. Cell-specific deletion of P2X7R will further
elucidate the role of microglia. P2X7 receptor signaling on retinal ganglion cell populations has
been demonstrated to have both neurotoxic168 and suggestively neuroprotective421 effects, which
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may be reflective of diverse and cell-specific roles194. Research into the role of microglia-specific
P2X7R signaling is limited by the absence of tools to selectively ablate the P2X7R on microglia
alone. The only readily available mouse strains have deleted P2X7R from the entire mouse174,185.
Mouse models utilizing Cre-inducible deletion of P2X7R will provide cell specific information about
P2X7R signaling (for example, see Douguet et al, 202196). Nevertheless, the models in use still
provide valuable information about P2X7R- and microglia-mediated inflammation.
Understanding the contribution of microglia activation to the loss of neural populations will
improve treatments of neurodegenerative diseases. Current therapeutics for glaucoma, a disease
of elevated intraocular pressure, rely on alleviation of IOP with minimal consideration to the
mechanistic effects on loss of RGCs. Determining the mechanisms of activation, the downstream
effects (examined in Chapters 2 and 3) and upstream effectors of microglia activation may aid in
developing new therapies to reduce retinal loss. While determining the order of events regarding
microglial activation and neuron loss requires considerable resources to answer fully, and therefore
remained outside the scope of this study, future experiments to answer the issue can focus on
determination upstream, concurrent, and downstream factors that are related to P2X7R stimulation.
5.3 P2X7R stimulation and microglial activation states
Despite our initial hypothesis that retinal administration of BzATP would lead to gene
expression of proinflammatory genes only, P2X7R stimulation resulted in upregulation of classical
activation genes Nos2 and Tnfa and alternative activation genes Arg1 and Chil3 was observed. In
vitro microglia paralleled this gene expression, with upregulation of Nos2 and Arg1 after 4 hr
exposure of either ATP or BzATP. Transient elevation of IOP in retinae from C57Bl/6J mice again
led to elevation of gene expression of Nos2, Tnfa, Arg1, and Chil3, all of which were reduced in
retinae from P2X7-/- mice.
P2X7R-induced upregulation of Tnfa and Nos2 is known to occur through NF-κB118,297. The
mechanism of upregulation of Arg1 with P2X7R stimulation of microglia is not known. Arg1 is
upregulated by transcription factor STAT656,169. The main activator of STAT6 is IL-4169. Stimulation
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of neuronal P2X7R with BzATP results in secretion of IL-4233. Within microglia, it remains to be
determined if IL-4 is released in a similar manner, and autostimulates IL-4R on microglia.
Our data were limited to gene expression measurements of whole retinae or on a
collections of cells. Once stimulated, gene and protein expression of NOS-2/iNOS (Nos2)19, TNFα (Tnfa)330, and Arg1 (Arg1)

419,434

colocalize to microglia within the CNS. Gene expression

elevation of Arg1 and Nos2 may simultaneously occur within individual microglia, or may occur
differently among microglia. Regardless, any signal differences are lost with bulk analysis. Future
experiments on individual cell types utilizing flow cytometry, cell specific isolation, or
immunohistochemical staining will provide more information on this matter.
If expression of Nos2 and Arg1 are upregulated simultaneously within the same cell, this
will add evidence to the complexity of P2X7R signaling. While the majority of consequences of
receptor stimulation in the literature are detrimental, protective actions occur too. For example
proliferation or cytotoxicity after exposure to ATP likely due to time or concentration differences1,89.
The upregulation of Arg1 may represent an early-phase anti-inflammatory response; transient
stimulation of P2X7R in microglia in the SOD-G93A mouse model of Amyotrophic Lateral Sclerosis
(ALS) led to expression alternative activation marker proteins ARG-1 and CD163. Interestingly,
elevation and subsequent reduction of these markers coincide with upregulation of autophagic
markers, with elevation of LC3B-II and reduction of phosphorylated mTOR occurred at the same
time103. Markers were then reversed with extended exposure to ATP for 6 hrs103. This transition
from adoption of anti-inflammatory markers to pro-inflammatory markers is observed in models of
spinal cord injury as well. 1 – 3 days after spinal cord injury, concurrent upregulation of classical
and alternative activation markers was observed in macrophage and microglia populations, before
transitioning to exclusively pro-inflammatory 14 days after injury4,200. The causes of the transition
are multifactorial. Myelin phagocytosis early after injury promoting alternative activation, and TNF
or iron-rich blood cells promoting classical activation213. Interestingly, administration of IL-4
promoted injury recovery and alternative activation of microglia115, while elimination of microglia
entirely exacerbates the injury23 pointing to the value of anti-inflammatory properties that microglia
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adopt early after injury. Of note, these anti-inflammatory effects of P2X7R have not been
specifically addressed in chronic models of elevation of IOP, leaving gaps of understanding of the
diversity of P2X7R actions. More detailed information regarding this transition may be addressed
with a full understanding of timecourse with P2X7R stimulation or elevation of IOP.
The multifaceted nature of P2X7R inflammatory response should be taken into
consideration with proposals for the use of antagonists to ameliorate diseases. Inhibition of P2X7R
exacerbated early negative effects in models of ischemia, ALS, and epilepsy, while contradictory
effects in models of Alzheimer’s were observed194. Inhibition of P2X7R in glaucoma models of
elevated IOP appear to reduce disease progression94,168,323,346,392, yet beneficial effects have been
noted. Transient elevation of IOP resulted in P2X7-/- retinae led to exacerbation of dysfunction in a
subtype of retinal ganglion cell421. Mechanical strain or BzATP applied to neurons resulted in
elevated release of neuroprotective cytokine IL-3233. IL-3 stimulation of microglia has recently been
shown to reduce plaque deposition and cognitive impairments in the 5xFAD mouse model of
Alzheimer’s disease272. Taken together, this suggests the need for exploration of therapies to target
intracellular effectors of P2X7R stimulation to determine if the beneficial effects of P2X7R inhibition
are recapitulated, or of combinations of therapies to preserve P2X7R-mediated benefits.
Moreover, manipulation of P2X7R-mediated inflammation can be accomplished with
influencing the balance between pro-and anti-inflammatory processes themselves. NOS2 and
arginase 1 utilize the same substrate in the Krebs cycle: L-arginine. Induction of arginase 1 and
depletes L-arginine and dampens NOS2 signaling57, and manipulation of arginase 1 is a therapeutic
option for acute retinal injuries112. Alterations or modulation of arginase 1 remain an interesting
direction to explore for amelioration of P2X7R-induced inflammation.
If further experimentation finds that Arg1 and Nos2 upregulated in distinct populations of
microglia rather than a mixed-activation state, it may elucidate information regarding the complexity
of P2X7R signaling in a time- or concentration-specific manner1,89. Immunohistochemistry is
currently being performed to determine cell-specific expression of cytokines to support work in
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Chapters 2 and 3. Evaluation of distinct microglia should also utilize cell-specific isolation or
RNAscope to delineate changes to each cell population.
Measuring concentration-specific effects of P2X7R stimulation in vivo are challenging.
Accurate measures of ATP concentration are difficult, and the distribution of ATP within the retina
have not been determined. Mechanical strain induced with elevation IOP is greatest at the optic
nerve head372, suggesting that ATP release throughout the retina may be inconsistent. Degradation
of ATP with ectonucleases such as NTPDase (CD39) further confounds assessments of ATP251,343.
A detailed assessment of differences in location-specific upregulation of pro- or anti-inflammatory
markers utilizing retinal whole mount models may offer clues as to differential exposure to ATP
while providing a snapshot of P2X7R signaling. Furthermore, although the spatial correlation
between morphology activation of microglial cells and retinal ganglion cell loss was not particularly
strong (Figure 2.7), an assessment of cell-specific gene expression differences may provide
information regarding local activation and inflammatory mechanisms by demonstrating if proinflammatory markers were upregulated where RGCs were reduced, or vice versa, where antiinflammatory markers were upregulated, and RGCs preserved.
Use of classical/M1 and alternative/M2 activation is a simplistic model of a complex
phenomenon26,336. Current developments utilizing RNA sequencing offer more nuanced
characterization of microglia268 that are not captured within this study. Nevertheless, arginase 1
has proven to be a useful marker and regulator to reduce Nos2-mediated release of reactive
oxygen species57, indicating that identification of expression of either Arg1 or Nos2 still provides
useful information. The pro-inflammatory state of classical activation is supported with expression
of Tnfa, a prototypical inflammatory marker, while Chil3 is upregulated with IL-4/STAT6
signaling67,329 (Figure S2.3), which has been implicated in repressing inflammatory enhancers and
NRLP3 expression in macrophages86. Nevertheless, terminology utilizing classical- or alternativeactivation remain in common use to explain complicated phenomena.
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5.4 P2X7R stimulation induces reactive astrocytes
Preliminary data presented in Chapter 3 indicates that P2X7R stimulation is sufficient to
induce gliosis. Retinal exposure to BzATP for 24 hrs induced gene expression elevation of
cytokines Tnfa, Il1a, and C1qa (Figure 3.1) that are linked to induction of reactive astrocytes231.
The same tissue samples exhibited elevated expression of transcripts associated with reactive
astrocytes, with more consistent upregulation of A1 neurotoxic polarization101,444 (Figure 3.3).
Elevation of IOP in C57Bl/6J mice also elevated expression of Tnfa and Il1a, with trending
upregulation of C1qa (Figure 3.2), while trending upregulation is observed of genes associated with
astrocyte inflammation (Figure 3.4). Interestingly, the upregulation of putative A2 genes CD14 and
Ptx3 was observed was highly significant, though the mean expression level was lower than A1
genes. While this may reflect a statistical phenomenon that will change with further
experimentation, this may also reflect a general anti-inflammatory reaction that is independent of
P2XR signaling. Importantly, upregulation of genes associated with reactive astrocytes was not
observed after IOP in P2X7R-/- (Figure 3.4), implying that P2X7R signaling is necessary to induce
A1-neurotoxic reactive astrocytes, while A2-neuroprotective astrocytes may be a common
counteractive anti-inflammatory pathway induced with any onset of inflammation. Furthermore, as
with microglial states that change with disease progression, the elevation of A2-specific transcripts
may reflect evaluation at an early timepoint.
The mechanisms connecting elevation of IOP to astrocyte inflammation through P2X7Rmediated release of cytokines is supported with previous data. Several studies demonstrate that
P2X7R inhibition reduces negative outcomes in models of IOP94,323,346,392, and P2X7R stimulation
induces expression of TNF-α and IL-1α through activation of NF-κB129,210,242. The data provided in
Chapters 2 and 3 offer a pathway whereby stimulation of microglial P2X7R may cause activation
of microglia, neurotoxic astrocytes, and subsequent death of neuron populations, although future
experiments are needed to address the details.
The cell-specific origin of the Tnfa, Il1a, and C1qa needs to be determined. Substantial
literature within the retina itself points to cell populations that release these cytokines that induce
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neurotoxic astrocytes. C1q expression is localized to microglia within the retina47 in accordance
with the role that the complement system plays in innate immunity, host defense, and synapse
engulfment14,293. Similar localization to microglia of protein IL-1α protein has been localized to spinal
cords15 or after infection with Toxoplasma gondii16. TNF-α is strongly expressed by microglia330,
but expression has also been found in cultured astrocytes360. While determining the specific role
that microglia play in inducing neurotoxic astrocytes can theoretically be determined through
microglia depletion deletion of microglia using PLX-3397 did not reduce loss of RGCs after ONC231.
LPS injection into mouse retinae did not eliminate upregulation of astrogliosis transcripts either,
although this was attributed to incomplete depletion of microglia231. A comparison of the effects of
LPS between depleted retinae and non-depleted retinae was not performed in that study, but would
offer useful information regarding the extent of inflammation reduction that occurs with microglia
elimination. That information, paired again with microglia-specific deletion of P2X7R, will elucidate
the role of P2X7R in microglia signaling; if no reduction of inflammation is observed, a parallel,
rather than sequential, induction of microglia and astroglial populations would appear to be a likelier
outcome. The role of reactive neurotoxic astrocytes in the loss of neural populations is currently
unknown101,230-232, but will be elucidated further with mechanistic targeting of specific cell
populations.
5.5 Intersection between P2X7R inflammation, phagocytosis, and autophagy
As P2X7R stimulation interacts with many intracellular signaling pathways210,314, we sought
to review the role it plays in microglia processes of autophagy and phagocytosis60. Absent
stimulation with ATP, P2X7R can act as a phagocytic scavenger for the CNS. Upon transient
stimulation with ATP, markers of induction of autophagy, such as LC3-II, are upregulated. However,
prolonged stimulation of P2X7R elevates the pH of the lysosome which likely contributes leak of
Cathepsin B out of the lysosome, leading to IL-1β release (Figure 4.3). Emerging data suggest that
autophagic or phagocytic processes and inflammatory processes may regulate each other in
microglia. Induction of autophagy degrades NLRP3 inflammasome components63,68,150, while
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receptors85,204,212,303,430,450. As microglia are the primary phagocytic cells in the CNS, P2X7R may
represent a central regulator within the CNS. However, the intricacies still need to be explored.
The discovery that P2X7R acts as a scavenger receptor within the CNS141, and that
scavenger activity is unaffected by channel inhibition140 offers new direction into use of P2X7R
therapeutics. P2X7R-mediated phagocytosis is believed to play a role in synaptic pruning during
neurogenesis140,141, yet its role in the adult brain is unclear.
The process of phagocytosis mediated by several mechanisms109, and the overall
phagocytic response to P2X7R stimulation is likely substrate and receptor dependent. While
stimulation of Stimulation of P2X7R reduced phagocytosis of apoptotic neurons140 it also
upregulates expression of phagocytic-mediated components, such as complement proteins
(Chapter 4). This is further complicated in disease models, where gross evaluation of outcomes
that incorporate P2X7R expression levels or location are confounded by the effects of P2X7Rmediated inflammation141 which contribute to cell death, or by possible compensatory phagocytic
mechanisms. Nevertheless, a comparison between the in vivo phagocytic effects of P2X7R
antagonism and deletion of the receptor may prove useful.
The intracellular signaling mechanisms, whereby microglia polarization influences
phagocytic properties, have not been clearly defined. Polarization away from the alternative
activation/M2 phenotype reduces phagocytosis due to reduction of STAT6 signaling56 or reduction
of TREM2 expression240. Although P2X7R signaling upregulated Arg1, the effects of stimulation on
STAT6 or TREM2, which itself signals via STAT6240, have not been studied. Interestingly, in vitro
phagocytosis of myelin reduces expression of inflammatory markers by microglia, and elevates
arginase 1 expression
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. Nevertheless, modulation of polarization via IL-4/STAT6 may prove

valuable to understand effects on phagocytosis, which is putatively reduced with P2X7R
stimulation. Understanding how modulates the M2-like genes modulates phagocytosis will have
implications for both the inflammatory and the phagocytic functions of P2X7R.
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P2X7R stimulation with ATP after LPS priming in vitro led to IL-1β release, and was
reduced by inhibition of Cathepsin B with CA-074 (Figure 4.3). In Bone-Marrow-Derived
Macrophages, CatB interaction with NLRP3 is necessary for Caspase 1 activation and pro-IL-1β
cleavage to its mature form, and may play a role in inflammatory processes in neurodegenerative
diseases165. Extended stimulation of P2X7R additionally led to elevation of pH of the lysosome402.
Lysosomal pH elevation is associated with destabilization, which may contribute to release of
lysosomal CatB and subsequent inflammation295. Therapies to reduce the pH of the lysosome, such
as elevation of cAMP

74,261,263

, or the use of acidic nanoparticles13,278, may reduce CatB-mediated

inflammation. Understanding the role of pH microglia lysosomes is hampered by a lack of tools to
measure pH in vivo coupled with the limitations of in vitro microglia research24,25. Nevertheless,
lysosomal modulation remains an interesting avenue of research.
5.6 Current clinical applications of P2X7R antagonists
The ultimate goal of this research is to improve on therapies to ameliorate inflammation in
neurodegenerative diseases. The enclosed dissertation focuses on a model of glaucoma whereby
elevated intraocular pressure creates strain and ATP release through pannexin hemichannels,
rather than ATP released through cell apoptosis. Clinical inhibition of P2X7R may prove a viable
therapeutic option in glaucoma or similar chronic neurodegenerative diseases. Therapeutic
inhibition of P2X7R has been proposed for general inflammatory conditions52, cancer52,97, retinalspecific diseases110, neuropsychiatric conditions27, as well as assorted neurodegenerative
diseases173. Currently, there are fifteen ongoing and completed clinical trials (and one terminated)
evaluating P2X7R and therapies for Rheumatoid arthritis, cancer, compound receptor occupancy,
or single-nucleotide polymorphisms (Clinicaltrials.gov, Table 5.1). Interestingly, application towards
neurodegenerative diseases has not been a focus of clinical evaluation of P2X7 receptor inhibitors,
though one inhibitor is capable of crossing the blood-brain barrier 411. Published literature of Phase
1 or 2 results indicates that P2X7R inhibitors have a favorable safety profile7,126,385,411. Yet clinical
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administration of P2X7R therapies has yielded disappointing results90,218. One hypothesis of this is
that this is because the new class of P2X7R inhibitors are noncompetitive allosteric modulators,

Table 5.1 Clinical trials utilizing P2X7R inhibition or assessment.
NCT
Study Title
Phase Intervention

Status

NCT00293189
NCT00471120
NCT00628095

NCT00697983
NCT00849134

NCT01440413

NCT01898767
NCT02082821
NCT02293811
NCT02587819
NCT03088644

NCT03437590

NCT03918616
NCT04116606
NCT04122937
NCT04126772

Gene-Polymorphies in the P2X7 Gene in
Patients With Osteoporotic Fractures
Feasibility Study: Accuracy of Biomarker in
Detection of Endometrial Cancer
Study of CE-224,535 A Twice Daily Pill To
Control Rheumatoid Arthritis In Patients
Who Have Not Totally Improved With
Methotrexate
Cohort Study on Associations Between
Purinergic Receptor SNPs and Osteoporosis
Risk
First Time in Human Study Evaluating the
Safety, Tolerability, Pharmacokinetics,
Pharmacodynamics and the Effect of Food
of Single Assending Doses of GSK1482160.
Study of the Response to a Neoadjuvant
Chemotherapy Based on the Antitumor
Immune Response in Localized Breast
Cancer
Eicosanoid Lipids by Airway Cells During
Infection With Human Rhinoviruses
A P2X7R Single Nucleotide Mutation
Promotes Chronic Allograft Vasculopathy
Decoding of the Expression of Tumor
Suppressor P2RX7 in Inflammatory and
Malignant Colonic Mucosa
Investigation of the Safety and Tolerability of
BSCT (Anti-nf-P2X7) 10% Ointment
A Study to Investigate P2X7 Receptor
Occupancy by JNJ-54175446 With the
Newly Developed P2X7 Receptor Positron
Emission Tomography (PET) Tracer 18FJNJ-64413739
A Positron Emission Tomography (PET)
Study to Investigate P2X7 Receptor
Occupancy by JNJ-55308942 Using [18F]JNJ-64413739
P2X7 Receptor, Inflammation and
Neurodegenerative Diseases
Antidepressant Trial With P2X7 Antagonist
JNJ-54175446
Defining Inflammation Related to Peritoneal
Carcinomatosis in Women With Ovarian or
Colon Cancer
Multimodal Imaging of MS Reveals the
Smoldering Inflammation

Obs. – Observational. From clinicaltrials.gov
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n/a
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assessment
P2X7 assay

Unknown

2, 3

CE-224,535

Completed

n/a
(obs.)

P2X7R
assessment

Completed

1

GSK1482160

Completed

n/a
(obs.)

P2X7R
assessment

Active

n/a
(obs.)
n/a
(obs.)
n/a
(obs.)

P2X7R
assessment
P2X7R
assessment
P2X7R
assessment

Completed

1

Completed

1

BSCT 10%
ointment
JNJ-54175446

1

JNJ-55308942

Completed

n/a
(obs.)
2

P2X7R
assessment
JNJ-54175446

Completed

n/a
(obs.)

P2X7R
assessment

Completed

n/a
(obs.)

P2X7R
assessment

Recruiting

Terminated

Completed
Unknown

Completed

Recruiting

rather than competitive inhibitors195 to augment target specificity or reduce therapeutic
concentration8,9,31. However, therapeutic inhibition of P2X7R with allosteric modulators is hindered
with conformational changes in the presence of ATP195. The high concentration of ATP in diseases
of high cell turnover, such as cancer89 may contribute to the lack of clinical efficacy. As the
mechanism of ATP release that ultimately stimulates P2X7R may be considerably less, or reduced
through coadministration of pannexin inhibitors, clinical application of P2X7R antagonists
may be a viable option for reducing neuroinflammatory contributions to glaucoma.
5.8 Summary
The varied roles P2X7R inhabits establish the receptor as a key mediator for inflammatory,
phagocytic, and autophagic pathways. Chapter 2 demonstrates the role of P2X7R stimulation in
activation of microglia, leading to morphological alterations and expression of both pro- and antiinflammatory genes. Chapters 2 and 3 indicate a mechanism by which elevated IOP stimulates
microglia P2X7R, induces reactive astrocytes, and leads to death of RGCs. Future experiments
are limited by the lack of models where the P2X7 receptor is deleted in a cell-specific manner.
Nevertheless, cell-specific isolation and more granular study of microglia activation in a locationbased manner will elucidate the role of microglia activation and astrogliosis in loss of RGC
populations. Chapter 4 reviews the diverse roles that P2X7R plays in phagocytosis modulating
autophagy in microglia, while outlining the need to explore the roles that autophagy, lysosomal
modulation, or cell-state modulation may play on P2X7R inflammatory processes. Modulation of
P2X7R may offer a viable option for abatement of inflammation in glaucoma, or for favoring
phagocytic processes of the receptor.
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